** = Publications listed in SCI/SSCI/Pubmed
** Bruch, PM; Dietrich, S; Finel, H; Boumendil, A; Greinix, H; Heinicke, T; Bethge, W; Beelen, D; Schmid, C; Martin, H; Castagna, L; Scheid, C; Schafer-Eckart, K; Bittenbring, J; Finke, J; Sengeloev, H; Heiblig, M; Cornelissen, J; Chevallier, P; Mohty, M; Robinson, S; Montoto, S; Dreger, P
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity matters
LEUKEMIA. 2023;
Doi: 10.1038/s41375-022-01782-z
Web of Science
PubMed
FullText
FullText_MUG
** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103
Doi: 10.1016/j.micinf.2023.105103
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tokaz, MC; Baldomero, H; Cowan, AJ; Saber, W; Greinix, H; Koh, MBC; Kröger, N; Mohty, M; Galeano, S; Okamoto, S; Chaudhri, N; Karduss, AJ; Ciceri, F; Colturato, VAR; Corbacioglu, S; Elhaddad, A; Force, LM; Frutos, C; León, AG; Hamad, N; Hamerschlak, N; He, N; Ho, A; Huang, XJ; Jacobs, B; Kim, HJ; Iida, M; Lehmann, L; de, Latour, RP; Percival, MM; Perdomo, M; Rasheed, W; Schultz, KR; Seber, A; Ko, BS; Simione, AJ; Srivastava, A; Szer, J; Wood, WA; Kodera, Y; Nagler, A; Snowden, JA; Weisdorf, D; Passweg, J; Pasquini, MC; Sureda, A; Atsuta, Y; Aljurf, M; Niederwieser, D
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Transplant Cell Ther. 2023; 29(4):279.e1-279.e10
Doi: 10.1016/j.jtct.2022.12.013
Web of Science
PubMed
FullText
FullText_MUG
** Zelić, Kerep, A; Olivieri, A; Schoemans, H; Lawitschka, A; Halter, J; Pulanic, D; Dickinson, A; Greinix, HT; Pavletic, SZ; Schultz, KR; Lee, SJ; Wolff, D
Chronic gvhd dictionary-eurograft cost action initiative consensus report.
Bone Marrow Transplant. 2023; 58(1):68-71
Doi: 10.1038/s41409-022-01837-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bojanic, I; Worel, N; Pacini, CP; Stary, G; Piekarska, A; Flinn, AM; Schell, KJ; Gennery, AR; Knobler, R; Lacerda, JF; Greinix, HT; Pulanic, D; Crossland, RE
Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.
Front Immunol. 2023; 14:1086006
Doi: 10.3389/fimmu.2023.1086006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Muhsen, IN; Galeano, S; Niederwieser, D; Koh, MBC; Ljungman, P; Machado, CM; Kharfan-Dabaja, MA; de, la, Camara, R; Kodera, Y; Szer, J; Rasheed, W; Cesaro, S; Hashmi, SK; Seber, A; Atsuta, Y; Saleh, MFM; Srivastava, A; Styczynski, J; Alrajhi, A; Almaghrabi, R; Abid, MB; Chemaly, RF; Gergis, U; Brissot, E; El, Fakih, R; Riches, M; Mikulska, M; Worel, N; Weisdorf, D; Greinix, H; Cordonnier, C; Aljurf, M
Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.
Lancet Haematol. 2023; 10(4):e295-e305
Doi: 10.1016/S2352-3026(23)00031-5
PubMed
FullText
FullText_MUG
** Muhsen, IN; Galeano, S; Niederwieser, D; Koh, MBC; Ljungman, P; Machado, CM; Kharfan-Dabaja, MA; de, la, Camara, R; Kodera, Y; Szer, J; Rasheed, W; Cesaro, S; Hashmi, SK; Seber, A; Atsuta, Y; Saleh, MFM; Srivastava, A; Styczynski, J; Alrajhi, A; Almaghrabi, R; Abid, MB; Chemaly, RF; Gergis, U; Brissot, E; El, Fakih, R; Riches, M; Mikulska, M; Worel, N; Weisdorf, D; Greinix, H; Cordonnier, C; Aljurf, M
Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review.
Lancet Haematol. 2023; 10(4):e284-e294
Doi: 10.1016/S2352-3026(23)00032-7
PubMed
FullText
FullText_MUG
** Correa, C; Gonzalez-Ramella, O; Baldomero, H; Basquiera, AL; Baena, R; Arcuri, L; Puga, B; Rosales, C; Chavez, M; Hernandez, C; Maldonado, B; Gomez-De Leon, A; Mendoza, N; Frutos, C; Aranda, L; Diaz, L; Hernandez, M; Seber, A; Karduss, A; Jaimovich, G; Martinez-Rolon, J; Bonfim, C; Greinix, H; Koh, MBC; Aljurf, M; Iida, M; Saber, W; Niederwieser, D; Atsuta, Y; Galeano, S
Increasing access to hematopoietic cell transplantation in Latin America: results of the 2018 LABMT activity survey and trends since 2012
BONE MARROW TRANSPL. 2022;
Doi: 10.1038/s41409-022-01630-9
Web of Science
PubMed
FullText
FullText_MUG
** Cuvelier, GDE; Schoettler, M; Buxbaum, NP; Pinal-Fernandez, I; Schmalzing, M; Distler, JHW; Penack, O; Santomasso, BD; Zeiser, R; Angstwurm, K; MacDonald, KPA; Kimberly, WT; Taylor, N; Bilic, E; Banas, B; Buettner-Herold, M; Sinha, N; Greinix, HT; Pidala, J; Schultz, KR; Williams, KM; Inamoto, Y; Cutler, C; Griffith, LM; Lee, SJ; Sarantopoulos, S; Pavletic, SZ; Wolff, D
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force
TRANSPL CELL THER. 2022; 28(8): 426-445.
Doi: 10.1016/j.jtct.2022.05.038
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Eikema, DJ; Koster, L; Penack, O; Yakoub-Agha, I; Montoto, S; Chabannon, C; Styczynski, J; Nagler, A; Robin, M; Robinson, S; Chalandon, Y; Mikulska, M; Schonland, S; Peric, Z; Ruggeri, A; Lanza, F; de Wreede, LC; Mohty, M; Basak, GW; Kroger, N
Improved outcome of patients with graft-versus-host disease after allogeneic hematopoietic cell transplantation for hematologic malignancies over time: an EBMT mega-file study
HAEMATOLOGICA. 2022; 107(5): 1054-1063.
Doi: 10.3324/haematol.2020.265769
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Milosevic, E; Babic, A; Iovino, L; Markovic, M; Grce, M; Greinix, H
Use of the NIH consensus criteria in cellular and soluble biomarker research in chronic graft-versus-host disease: A systematic review
FRONT IMMUNOL. 2022; 13: 1033263
Doi: 10.3389/fimmu.2022.1033263
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Niederwieser, D; Baldomero, H; Bazuaye, N; Bupp, C; Chaudhri, N; Corbacioglu, S; Elhaddad, A; Frutos, C; Galeano, S; Hamad, N; Hamidieh, AA; Hashmi, S; Ho, A; Horowitz, MM; Iida, M; Jaimovich, G; Karduss, A; Kodera, Y; Kroger, N; de Latour, RP; Lee, JW; Martinez-Rolon, J; Pasquini, MC; Passweg, J; Paulson, K; Seber, A; Snowden, JA; Srivastava, A; Szer, J; Weisdorf, D; Worel, N; Koh, MBC; Aljurf, M; Greinix, H; Atsuta, Y; Saber, W
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
HAEMATOLOGICA. 2022; 107(5): 1045-1053.
Doi: 10.3324/haematol.2021.279189
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Kraßnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P
Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies.
Open Forum Infect Dis. 2022; 9(8): ofac393
Doi: 10.1093/ofid/ofac393
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Pansy, K; Wenzl, K; Strobl, J; Baumgartner, C; Szmyra, MM; Waha, JE; Wolf, A; Tomazic, PV; Steinbauer, E; Steinwender, M; Friedl, S; Weniger, M; Küppers, R; Pichler, M; Greinix, HT; Stary, G; Ramsay, AG; Apollonio, B; Feichtinger, J; Beham-Schmid, C; Neumeister, P; Deutsch, AJ
Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.
Int J Mol Sci. 2022; 23(14):
Doi: 10.3390/ijms23147874
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Perovic, V; Sabol, I; Grce, M; Inngjerdingen, M; Pulanic, D; Peric, Z; Peczynski, C; Polge, E; Koenecke, C; Dickinson, A; Greinix, H; Basak, G; Penack, O; Scherwath, A; Barata, A; Olivieri, A; Lawitschka, A; Mensah-Glanowska, P; Andrikovics, H; Schoemans, H; Wolff, D
Practice patterns in chronic graft-versus-host disease patient management and patient reported outcome measures across the EBMT allogeneic transplantation network
BONE MARROW TRANSPL. 2022;
Doi: 10.1038/s41409-022-01733-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Alseraihy, A; McGrath, E; Niederwieser, D; Chabannon, C; Szer, J; Mohty, M; Kharfan-Dabaja, MA; Orchard, K; Schwartz, J; Rasheed, W; Koh, M; Kroger, N; Kodera, Y; El Fakih, R; Worel, N; Manson, L; Rintala, T; Tabakhi, A; Savani, B; Gergis, U; Sureda, A; Eldridge, PW; Yakoub-Agha, I; Hamadani, M; Weisdorf, D; Greinix, H; Aljurf, M
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy
TRANSPL CELL THER. 2022; 28(8): 455-462.
Doi: 10.1016/j.jtct.2022.04.003
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Ayuk, F; Zeiser, R
Extracorporeal photopheresis in acute and chronic steroid-refractory graft-versus-host disease: an evolving treatment landscape
LEUKEMIA. 2022;
Doi: 10.1038/s41375-022-01701-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Phelan, R; Im, A; Hunter, RL; Inamoto, Y; Lupo-Stanghellini, MT; Rovo, A; Badawy, SM; Burns, L; Eissa, H; Murthy, HS; Prasad, P; Sharma, A; Suelzer, E; Agrawal, V; Aljurf, M; Baker, K; Basak, GW; Buchbinder, D; DeFilipp, Z; Grkovic, LD; Dias, A; Einsele, H; Eisenberg, ML; Epperla, N; Farhadfar, N; Flatau, A; Gale, RP; Greinix, H; Hamilton, BK; Hashmi, S; Hematti, P; Jamani, K; Maharaj, D; Murray, J; Naik, S; Nathan, S; Pavletic, S; Peric, Z; Pulanic, D; Ross, R; Salonia, A; Sanchez-Ortega, I; Savani, BN; Schechter, T; Shah, AJ; Smith, SM; Snowden, JA; Steinberg, A; Tremblay, D; Vij, SC; Walker, L; Wolff, D; Yared, JA; Schoemans, H; Tichelli, A
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
BONE MARROW TRANSPL. 2022;
Doi: 10.1038/s41409-022-01591-z
Web of Science
PubMed
FullText
FullText_MUG
** Phelan, R; Im, A; Hunter, RL; Inamoto, Y; Lupo-Stanghellini, MT; Rovo, A; Badawy, SM; Burns, L; Eissa, H; Murthy, HS; Prasad, P; Sharma, A; Suelzer, E; Agrawal, V; Aljurf, M; Baker, K; Basak, GW; Buchbinder, D; DeFilipp, Z; Grkovic, LD; Dias, A; Einsele, H; Eisenberg, ML; Epperla, N; Farhadfar, N; Flatau, A; Gale, RP; Greinix, H; Hamilton, BK; Hashmi, S; Hematti, P; Jamani, K; Maharaj, D; Murray, J; Naik, S; Nathan, S; Pavletic, S; Peric, Z; Pulanic, D; Ross, R; Salonia, A; Sanchez-Ortega, I; Savani, BN; Schechter, T; Shah, AJ; Smith, SM; Snowden, JA; Steinberg, A; Tremblay, D; Vij, SC; Walker, L; Wolff, D; Yared, JA; Schoemans, H; Tichelli, A
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation
TRANSPL CELL THER. 2022; 28(6):
Doi: 10.1016/j.jtct.2021.10.0132666-6367
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Uhl, B; Prochazka, KT; Fechter, K; Pansy, K; Greinix, HT; Neumeister, P; Deutsch, AJ
Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.
World J Gastrointest Oncol. 2022; 14(1): 153-162.
Doi: 10.4251/wjgo.v14.i1.153
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Aljurf, M; Anthias, C; Buser, AS; Cody, M; Fechter, M; Galeano, S; Greinix, HT; Kisch, AM; Koh, MBC; Mengling, T; Nicoloso, G; Niederwieser, D; Pulsipher, MA; Seber, A; Shaw, BE; Stefanski, HE; Switzer, GE; Szer, J; van Walraven, SM; Yang, H; Halter, JP
Suitability of haematopoietic cell donors: updated consensus recommendations from the WBMT standing committee on donor issues
LANCET HAEMATOL. 2022; 9(8): E605-E614.
Web of Science
PubMed
** Greinix, H
CAR-T cells-Real-time experience applying CAR-T cells-What we have learned so far
MEMO-MAG EUR MED ONC. 2022; 15(3): 173-175.
Doi: 10.1007/s12254-022-00830-9
Web of Science
FullText
FullText_MUG
** Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT
Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142.
[Poster]
Web of Science
FullText
** Garderet, L; Gras, L; Koster, L; D'Souza, A; Estrada-Merly, N; Hari, P; Saber, W; Cowan, AJ; Iida, M; Okamoto, S; Takamatsu, H; Mizuno, S; Kawamura, K; Kodera, Y; Hamad, N; Ko, BS; Liam, C; Ho, KW; Goh, AS; Tan, SK; Elhaddad, AM; Bazarbachi, A; Chaudhry, QUN; Alfar, R; Bekadja, MA; Benakli, M; Ortiz, CAF; Riva, E; Galeano, S; Bass, F; Mian, HS; McCurdy, A; Wang, FR; Neumann, D; Koh, M; Snowden, JA; Schonland, S; McLornan, DP; Hayden, PJ; Sureda, A; Greinix, HT; Aljurf, M; Atsuta, Y; Niederwieser, D
Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers
BLOOD. 2022; 140: 4839-4842.
Doi: 10.1182/blood-2022-164619
Web of Science
FullText
FullText_MUG
** Garderet, L; Gras, L; Koster, L; D'Souza, A; Estrada-Merly, N; Hari, P; Saber, W; Cowan, AJ; Iida, M; Okamoto, S; Takamatsu, H; Mizuno, S; Kawamura, K; Kodera, Y; Hamad, N; Ko, BS; Liam, C; Ho, KW; Goh, AS; Tan, SK; Elhaddad, AM; Bazarbachi, A; Chaudhry, QUN; Alfar, R; Bekadja, MA; Benakli, M; Ortiz, CAF; Riva, E; Galeano, S; Bass, F; Mian, HS; McCurdy, A; Wang, FR; Neumann, D; Koh, M; Snowden, JA; Schonland, S; McLornan, DP; Hayden, PJ; Sureda, A; Greinix, HT; Aljurf, M; Atsuta, Y; Niederwieser, D
International Differences in Baseline Characteristics and Practice Patterns in Patients with NEWLY Diagnosed Multiple Myeloma Undergoing Upfront Autologous STEM Cell Transplantation
BLOOD. 2022; 140: 5225-5227.
Doi: 10.1182/blood-2022-165010
Web of Science
FullText
FullText_MUG
** Garderet, L; Grass, L; Koster, L; D'Souza, A; Estrada, N; Parameswaran, H; Saber, W; Cowan, A; Iida, M; Shin, O; Takamatsu, H; Mitzuno, S; Kawamura, K; Kodera, Y; Hamad, N; Ko, BS; Liam, C; Wah, HK; Goh, AS; Tan, SK; Elhaddad, A; Bazarbachi, A; Chaudhry, Q; Alfar, R; Bekadja, A; Benakli, M; Frutos, C; Riva, E; Galaneo, S; Bass, F; Mian, H; Figueiredo, A; Wang, FR; Neumann, D; Koh, M; Snowden, J; Schoenland, S; Yakoub-Agka, I; Greinix, H; Aljurf, M; Atsuta, Y; Niederwieser, D
International differences in baseline characteristics and practice patterns in newly diagnosed multiple myeloma (MM) patients undergoing upfront autologous stem cell transplantation
BONE MARROW TRANSPL. 2022; 57(SUPPL 1):44-45.
[Poster]
Web of Science
** Langer, R; Lelas, A; Desnica, L; Rittenschober, M; Piekarska, A; Sadowska-Klasa, A; Sabol, I; Greinix, H; Dickinson, A; Inngjerdingen, M; Lawitschka, A; Vrhovac, R; Pulanic, D; Klein, S; Middeke, JM; Grube, M; Holler, E; Edinger, M; Herr, W; Wolff, D
Prospective analysis of the incidence and outcome of late acute and chronic graft-versus-host disease from multiple transplant centers
BONE MARROW TRANSPL. 2022; 57(SUPPL 1):207-208.
[Poster]
Web of Science
** Locke, FL; Chou, J; Vardhanabhuti, S; Perbost, R; Dreger, P; Hill, BT; Lee, C; Zinzani, PL; Kroeger, N; Lopez-Guillermo, A; Greinix, H; Zhang, WS; Tiwari, G; To, CA; Cheng, PC; Bot, A; Shen, R; Filosto, S; Galon, J
Association of pretreatment (preTx) tumor characteristics and clinical outcomes following second-line (2L) axicabtagene ciloleucel (axi-cel) versus standard of care (SOC) in patients (pts) with relapsed/refractory (R/R) large B-cell lymphoma (LBCL).
J CLIN ONCOL. 2022; 40(16):
[Oral Communication]
Web of Science
** Monch, A; Prochazka, K; Greinix, H; Neumeister, P; Deutsch, A; Uhl, B
Specific clinical, serologic, and histopathologic Parameters are associated with inferior Survival of Patients with primary CNS Lymphoma
ONCOL RES TREAT. 2022; 45(SUPPL 2):61-61.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Wenzl, K; Arra, A; Novak, JP; Szmyra, M; Haingartner, S; Ramsay, AG; Novak, AJ; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, AJA
Loss of Nr4a1 Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
BLOOD. 2022; 140: 2038-2039.
Doi: 10.1182/blood-2022-163034
Web of Science
FullText
FullText_MUG
** Rudzki, JD; Jaeger, U; Wolf, D; Petzer, A; Greil, R; Peters, C; Greinix, HT; Attarbaschi, A; Buxhofer-Ausch, V; Girschikofsky, M; Holter, W; Leisch, M; Neumeister, P; Schlenke, P; Schmitt, CA; Schwinger, W; Worel, N; Wohlfarth, P
Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
BLOOD. 2022; 140: 6661-6663.
Doi: 10.1182/blood-2022-167603
Web of Science
FullText
FullText_MUG
** Szmyra, MM; Haingartner, S; Jantscher, S; Pansy, K; Uhl, B; Greinix, HT; Neumeister, P; Bernhart, E; Beham-Schmid, C; Dengler, MA; Klosch, B; Deutsch, AJA
The Flavonoid Brusatol Induces Apoptosis in Aggressive Lymphoma Cells and Exhibits Synergistic Effect with Venetoclax
BLOOD. 2022; 140: 4945-4946.
Doi: 10.1182/blood-2022-166678
[Poster]
Web of Science
FullText
FullText_MUG
** Koh, MBC; Halter, JP; Greinix, HT; Aljurf, M; Worel, N
Authors' reply
LANCET HAEMATOL. 2022; 9(11): E803-E804.
Doi: 10.1016/S2352-3026(22)00302-7
Web of Science
PubMed
FullText
FullText_MUG
** Kornauth, C; Pemovska, T; Vladimer, GI; Bayer, G; Bergmann, M; Eder, S; Eichner, R; Erl, M; Esterbauer, H; Exner, R; Felsleitner-Hauer, V; Forte, M; Gaiger, A; Geissler, K; Greinix, HT; Gstöttner, W; Hacker, M; Hartmann, BL; Hauswirth, AW; Heinemann, T; Heintel, D; Hoda, MA; Hopfinger, G; Jaeger, U; Kazianka, L; Kenner, L; Kiesewetter, B; Krall, N; Krajnik, G; Kubicek, S; Le, T; Lubowitzki, S; Mayerhoefer, ME; Menschel, E; Merkel, O; Miura, K; Müllauer, L; Neumeister, P; Noesslinger, T; Ocko, K; Öhler, L; Panny, M; Pichler, A; Porpaczy, E; Prager, GW; Raderer, M; Ristl, R; Ruckser, R; Salamon, J; Schiefer, AI; Schmolke, AS; Schwarzinger, I; Selzer, E; Sillaber, C; Skrabs, C; Sperr, WR; Srndic, I; Thalhammer, R; Valent, P; van, der, Kouwe, E; Vanura, K; Vogt, S; Waldstein, C; Wolf, D; Zielinski, CC; Zojer, N; Simonitsch-Klupp, I; Superti-Furga, G; Snijder, B; Staber, PB
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Cancer Discov. 2022; 12(2):372-387
Doi: 10.1158/2159-8290.CD-21-0538
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Crossland, RE; Norden, J; Ghimire, S; Juric, MK; Pearce, KF; Lendrem, C; Collin, M; Mischak-Weissinger, E; Holler, E; Greinix, HT; Dickinson, AM
Profiling Tissue and Biofluid miR-155-5p, miR-155*, and miR-146a-5p Expression in Graft vs. Host Disease.
FRONT IMMUNOL. 2021; 12(5): 639171-639171.
Doi: 10.3389/fimmu.2021.639171
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** DeFilipp, Z; Couriel, DR; Lazaryan, A; Bhatt, VR; Buxbaum, NP; Alousi, AM; Olivieri, A; Pulanic, D; Halter, JP; Henderson, LA; Zeiser, R; Gooley, TA; MacDonald, KPA; Wolff, D; Schultz, KR; Paczesny, S; Inamoto, Y; Cutler, CS; Kitko, CL; Pidala, JA; Lee, SJ; Socie, G; Sarantopoulos, S; Pavletic, SZ; Martin, PJ; Blazar, BR; Greinix, HT
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2020 Treatment of Chronic GVHD Report
TRANSPL CELL THER. 2021; 27(9): 729-737.
Doi: 10.1016/j.jtct.2021.05.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Domingo-Domenech, E; Duarte, RF; Boumedil, A; Onida, F; Gabriel, I; Finel, H; Arcese, W; Browne, P; Beelen, D; Kobbe, G; Veelken, H; Arranz, R; Greinix, H; Lenhoff, S; Poiré, X; Ribera, JM; Thompson, J; Zuckerman, T; Mufti, GJ; Cortelezzi, A; Olavarria, E; Dreger, P; Sureda, A; Montoto, S
Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides and Sézary syndrome. An updated experience of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2021; 11(2):
Doi: 10.1038/s41409-020-01197-3
Web of Science
PubMed
FullText
FullText_MUG
** Eglseer, D; Bauer, S; Huber-Kraßnitzer, B; Greinix, H
Malnutrition risk prior to hematopoietic stem cell transplantation predicts mortality in adults.
Bone Marrow Transplant. 2021; 56(9): 2268-2271.
Doi: 10.1038/s41409-021-01292-z
Web of Science
PubMed
FullText
FullText_MUG
** El Fakih, R; Greinix, H; Koh, M; Shaw, B; Mohty, M; Al Nahedh, M; Saber, W; Kharfan-Dabaja, MA; Perales, MA; Savani, BN; Majhail, NS; Passweg, JR; Sureda, A; Ahmed, SO; Gluckman, E; Riches, M; El-Jawahri, A; Rondelli, D; Srivastava, A; Faulkner, L; Atsuta, Y; Ballen, KK; Rasheed, W; Okamoto, S; Seber, A; Chao, N; Kröger, N; Kodera, Y; Szer, J; Hashmi, SK; Horowitz, MM; Weisdorf, D; Niederwieser, D; Aljurf, M
Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program.
TRANSPL CELL THER. 2021; 27(3): 267.e1-267267.
Doi: 10.1016/j.jtct.2020.12.015
Web of Science
PubMed
FullText
FullText_MUG
** Giebel, S; Labopin, M; Sobczyk-Kruszelnicka, M; Stelljes, M; Byrne, JL; Fegueux, N; Beelen, DW; Rovira, M; Spyridonidis, A; Blaise, D; Bornhäuser, M; Karadogan, I; Savani, BN; Nagler, A; Mohty, M; Principal investigators of the contributing institutions
Total body irradiation + fludarabine compared to busulfan + fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT.
Bone Marrow Transplant. 2021; 56(2):481-491
Doi: 10.1038/s41409-020-01050-7
Web of Science
PubMed
FullText
FullText_MUG
** Harrison, N; Grabmeier-Pfistershammer, K; Graf, A; Trapin, D; Tauber, P; Aberle, JH; Stiasny, K; Schmidt, R; Greinix, H; Rabitsch, W; Ramharter, M; Burgmann, H; Pickl, WF; Bahrs, C
Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination.
VACCINES-BASEL. 2021; 9(8):
Doi: 10.3390/vaccines9080908
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E
Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621
Doi: 10.1097/HS9.0000000000000621
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P
Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207
Doi: 10.1007/s00520-021-06059-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Sareban, N; Stradner, M; Rosskopf, K; Reisinger, AC; Eller, P; Schörghuber, M; Toller, W; Sloup, Z; Prüller, F; Gütl, K; Pilz, S; Rosenkranz, AR; Greinix, HT; Krause, R; Schlenke, P; Schilcher, G
Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Ann Intensive Care. 2021; 11(1): 73
Doi: 10.1186/s13613-021-00867-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kitko, CL; Pidala, J; Schoemans, HM; Lawitschka, A; Flowers, ME; Cowen, EW; Tkaczyk, E; Farhadfar, N; Jain, S; Steven, P; Luo, ZHK; Ogawa, Y; Stern, M; Yanik, GA; Cuvelier, GDE; Cheng, GS; Holtan, SG; Schultz, KR; Martin, PJ; Lee, SJ; Pavletic, SZ; Wolff, D; Paczesny, S; Blazar, BR; Sarantopoulos, S; Socie, G; Greinix, H; Cutler, C
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group Report
TRANSPL CELL THER. 2021; 27(7): 545-557.
Doi: 10.1016/j.jtct.2021.03.033
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lawitschka, A; Brunmair, M; Bauer, D; Zubarovskaya, N; Felder-Puig, R; Strahm, B; Bader, P; Strauss, G; Albert, M; von Luettichau, I; Greinix, H; Wolff, D; Peters, C
Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children : Results of a prospective study on behalf of the German-Austrian-Swiss GVHD Consortium.
Wien Klin Wochenschr. 2021; 133(1-2):41-51
Doi: 10.1007/s00508-020-01641-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pidala, J; Kitko, C; Lee, SJ; Carpenter, P; Cuvelier, GDE; Holtan, S; Flowers, ME; Cutler, C; Jagasia, M; Gooley, T; Palmer, J; Randolph, T; Levine, JE; Ayuk, F; Dignan, F; Schoemans, H; Tkaczyk, E; Farhadfar, N; Lawitschka, A; Schultz, KR; Martin, PJ; Sarantopoulos, S; Inamoto, Y; Socie, G; Wolff, D; Blazar, B; Greinix, H; Paczesny, S; Pavletic, S; Hill, G
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report
TRANSPL CELL THER. 2021; 27(8): 632-641.
Doi: 10.1016/j.jtct.2021.03.029
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rupp, J; Dreo, B; Gütl, K; Fessler, J; Moser, A; Haditsch, B; Schilcher, G; Matzkies, LM; Steinmetz, I; Greinix, H; Stradner, MH
T Cell Phenotyping in Individuals Hospitalized with COVID-19.
J Immunol. 2021; 206(7):1478-1482
Doi: 10.4049/jimmunol.2001034
Web of Science
PubMed
FullText
FullText_MUG
** Scheidl, S; Avian, A; Flick, H; Gaal, S; Greinix, H; Olschewski, H
Impact of Smoking Behavior on Survival Following Allogeneic Hematopoietic Stem Cell Transplantation - Smoking Cessation Matters.
Nicotine Tob Res. 2021; 23(10):1708-1715
Doi: 10.1093/ntr/ntab070
Web of Science
PubMed
FullText
FullText_MUG
** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I
CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742
Doi: 10.3389/fimmu.2021.803742
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Halwachs, B; Bayer, N; Huber-Krassnitzer, B; Schulz, E; Uhl, B; Gaksch, L; Hatzl, S; Bachmayr, V; Kleissl, L; Kump, P; Deutsch, A; Stary, G; Greinix, H; Gorkiewicz, G; Högenauer, C; Neumeister, P
Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
Ther Adv Hematol. 2021; 12:20406207211058333
Doi: 10.1177/20406207211058333
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Toenges, R; Greinix, H; Lawitschka, A; Halter, J; Baumgartner, A; Simon, A; Arends, J; Jager, P; Middeke, M; Hilgendorf, I; Klein, S; Wagner-Drouet, EM; Schmid, C; Bug, G; Wolff, D
Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers
CLIN NUTR. 2021; 40(4): 1571-1577.
Doi: 10.1016/j.clnu.2021.02.030
Web of Science
PubMed
FullText
FullText_MUG
** Williams, KM; Inamoto, Y; Im, A; Hamilton, B; Koreth, J; Arora, M; Pusic, I; Mays, JW; Carpenter, PA; Luznik, L; Reddy, P; Ritz, J; Greinix, H; Paczesny, S; Blazar, BR; Pidala, J; Cutler, C; Wolff, D; Schultz, KR; Pavletic, SZ; Lee, SJ; Martin, PJ; Socie, G; Sarantopoulos, S
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report
TRANSPL CELL THER. 2021; 27(6): 452-466.
Doi: 10.1016/j.jtct.2021.02.035
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Herzberg, PY; Herrmann, A; Pavletic, SZ; Heussner, P; Mumm, F; Höfer, C; Hilgendorf, I; Hemmati, PG; Holler, E; Greinix, H; Mitchell, SA
Post-transplant multimorbidity index and quality of life in patients with chronic graft-versus-host disease-results from a joint evaluation of a prospective German multicenter validation trial and a cohort from the National Institutes of Health.
Bone Marrow Transplant. 2021; 56(1):243-256
Doi: 10.1038/s41409-020-01017-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Radojcic, V; Lafyatis, R; Cinar, R; Rosenstein, RK; Cowen, EW; Cheng, GS; Sheshadri, A; Bergeron, A; Williams, KM; Todd, JL; Teshima, T; Cuvelier, GDE; Holler, E; McCurdy, SR; Jenq, RR; Hanash, AM; Jacobsohn, D; Santomasso, BD; Jain, S; Ogawa, Y; Steven, P; Luo, ZK; Dietrich-Ntoukas, T; Saban, D; Bilic, E; Penack, O; Griffith, LM; Cowden, M; Martin, PJ; Greinix, HT; Sarantopoulos, S; Socie, G; Blazar, BR; Pidala, J; Kitko, CL; Couriel, DR; Cutler, C; Schultz, KR; Pavletic, SZ; Lee, SJ; Paczesny, S
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report
TRANSPL CELL THER. 2021; 27(10): 817-835.
Doi: 10.1016/j.jtct.2021.06.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Shaw, BE; Aljurf, M; Koh, M; Seber, A; Weisdorf, D; Schwartz, J; Galeano, S; Kodera, Y; Eldridge, PW; Hashmi, S; Atsuta, Y; Szer, J; Saber, W; Niederwieser, D; Greinix, HT; Worldwide Network for Blood & Marrow Transplantation
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow Transplantation.
TRANSPL CELL THER. 2021; 27(3): 270.e1-270270.
Doi: 10.1016/j.jtct.2020.11.019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lelas, A; Greinix, HT; Wolff, D; Eissner, G; Pavletic, SZ; Pulanic, D
Von Willebrand Factor, Factor VIII, and Other Acute Phase Reactants as Biomarkers of Inflammation and Endothelial Dysfunction in Chronic Graft-Versus-Host Disease
FRONT IMMUNOL. 2021; 12: 676756
Doi: 10.3389/fimmu.2021.676756
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pansy, K; Uhl, B; Krstic, J; Szmyra, M; Fechter, K; Santiso, A; Thüminger, L; Greinix, H; Kargl, J; Prochazka, K; Feichtinger, J; Deutsch, AJ
Immune Regulatory Processes of the Tumor Microenvironment under Malignant Conditions.
Int J Mol Sci. 2021; 22(24):
Doi: 10.3390/ijms222413311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT
Metabolomics: a novel way to diagnose cGVHD?
BLOOD. 2021; 139(2): 161-162.
Doi: 10.1182/blood.2021014041
Web of Science
PubMed
FullText
FullText_MUG
** Lawitschka, A; Brunmair, M; Bauer, D; Zubarovskaya, N; Felder-Puig, R; Strahm, B; Bader, P; Strauss, G; Albert, M; von Luettichau, I; Greinix, H; Wolff, D; Peters, C
Psychometric properties of the Activities Scale for Kids-performance after allogeneic hematopoietic stem cell transplantation in adolescents and children Results of a prospective study on behalf of the German-Austrian-Swiss GVHD consortium (vol 133, pg 41, 2020)
WIEN KLIN WOCHENSCHR. 2021; 133(13-14): 729-730.
Doi: 10.1007/s00508-021-01902-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Foßelteder, J; Schlacher, A; Pabst, G; Amtmann, B; Schöll, W; Kashofer, K; Beham-Schmid, C; Schlenke, P; Greinix, HT; Sill, H; Woelfler, A; Zebisch, A; Reinisch, A
Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-147919
[Poster]
Web of Science
FullText
FullText_MUG
** Gaksch, L; Pansy, K; Schukoff, T; Greinix, H; Beham-Schmid, C; Neumeister, P; Prochazka, K; Deutsch, A
Distinct expression profile of chemokine receptors is associated with the pathogenesis of follicular lymphoma
ONCOL RES TREAT. 2021; 44: 152-152.
[Poster]
Web of Science
** Pabst, G; Foßelteder, J; Schlacher, A; Auinger, L; Martinez-Krams3, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, C; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-149591
[Poster]
Web of Science
FullText
FullText_MUG
** Peric, Z; Schoemans, H; Peczynski, C; Koenecke, C; Moiseev, IS; Basak, GW; Boreland, W; Greinix, HT; Wolff, D; Penack, O
Management of Steroid-Refractory Graft-Versus-Host Disease - a Survey By the Transplant Complications Working Party of the EBMT
BLOOD. 2021; 138:
Doi: 10.1182/blood-2021-152305
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Pfistershammer, KG; Harrison, N; Graf, A; Trapin, D; Tauber, P; Aberle, JH; Stiasny, K; Schmidt, R; Greinix, H; Ramharter, M; Burgmann, H; Pickl, WF; Bahrs, C
The TBE-specific lymphocyte response after HSCT but before vaccination predicts the rapid establishment of humoral immunity after TBE vaccination
EUR J IMMUNOL. 2021; 51: 322-322.
[Poster]
Web of Science
** Knobler, R; Arenberger, P; Arun, A; Assaf, C; Bagot, M; Berlin, G; Bohbot, A; Calzavara-Pinton, P; Child, F; Cho, A; French, LE; Gennery, AR; Gniadecki, R; Gollnick, HPM; Guenova, E; Jaksch, P; Jantschitsch, C; Klemke, C; Ludvigsson, J; Papadavid, E; Scarisbrick, J; Schwarz, T; Stadler, R; Wolf, P; Zic, J; Zouboulis, C; Zuckermann, A; Greinix, H
European dermatology forum: Updated guidelines on the use of extracorporeal photopheresis 2020 - Part 2.
J Eur Acad Dermatol Venereol. 2021; 35(1):27-49
Doi: 10.1111/jdv.16889
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Algwaiz, G; Aljurf, M; Koh, M; Horowitz, MM; Ljungman, P; Weisdorf, D; Saber, W; Kodera, Y; Szer, J; Jawdat, D; Wood, WA; Brazauskas, R; Lehmann, L; Pasquini, MC; Seber, A; Lu, PH; Atsuta, Y; Riches, M; Perales, MA; Worel, N; Okamoto, S; Srivastava, A; Chemaly, RF; Cordonnier, C; Dandoy, CE; Wingard, JR; Kharfan-Dabaja, MA; Hamadani, M; Majhail, NS; Waghmare, AA; Chao, N; Kröger, N; Shaw, B; Mohty, M; Niederwieser, D; Greinix, H; Hashmi, SK, , WBMT, and, the, CIBMTR, Health, Services, and, International, Studies, Committee, , WBMT, and, the, CIBMTR, Health, Services, and, International, Studies, Committee
Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee.
Biol Blood Marrow Transplant. 2020; 26(12):2181-2189
Doi: 10.1016/j.bbmt.2020.07.021
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bonifazi, F; Rubio, MT; Bacigalupo, A; Boelens, JJ; Finke, J; Greinix, H; Mohty, M; Nagler, A; Passweg, J; Rambaldi, A; Socie, G; Solano, C; Walker, I; Barosi, G; Kröger, N
Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel.
Bone Marrow Transplant. 2020; 55(6):1093-1102
Doi: 10.1038/s41409-020-0792-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Cowan, AJ; Baldomero, H; Atsuta, Y; Mikhael, J; Aljurf, M; Seber, A; Greinix, H; Koh, M; Worel, N; Libby, EN; Pasquini, M; Galeano, S; Saber, W; Iida, M; Jaimovich, G; Rolon, JM; Kodera, Y; Benakli, M; Nosa, BG; Elhaddad, A; Szer, J; Passweg, J; Kroeger, N; Weisdorf, D; Niederwieser, D
The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study.
Biol Blood Marrow Transplant. 2020; 26(12):2372-2377
Doi: 10.1016/j.bbmt.2020.08.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Attarbaschi, A; Girschikofsky, M; Greil, R; Holter, W; Neumeister, P; Peters, C; Petzer, A; Rudzki, J; Schlenke, P; Schmitt, CA; Schwinger, W; Wolf, D; Worel, N; Jaeger, U
Ensuring center quality, proper patient selection and fair access to chimeric antigen receptor T-cell therapy: position statement of the Austrian CAR-T Cell Network.
MEMO-MAG EUR MED ONC. 2020;
Doi: 10.1007/s12254-020-00582-4
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Harrison, N; Grabmeier-Pfistershammer, K; Graf, A; Schwarzinger, I; Aberle, JH; Stiasny, K; Greinix, H; Rabitsch, W; Kalhs, P; Ramharter, M; Burgmann, H; Forstner, C
Humoral immune response to tick-borne encephalitis vaccination in allogeneic blood and marrow graft recipients.
NPJ Vaccines. 2020; 5:67-67
Doi: 10.1038/s41541-020-00215-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT
Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283
Doi: 10.1002/hon.2727
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Helmberg, W; Sipurzynski, S; Groselje-Strehle, A; Greinix, H; Schlenke, P
Does Offline Beat Inline Treatment: Investigation into Extracorporeal Photopheresis.
Transfus Med Hemother. 2020; 47(3):198-204
Doi: 10.1159/000506750
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Knobler, R; Arenberger, P; Arun, A; Assaf, C; Bagot, M; Berlin, G; Bohbot, A; Calzavara-Pinton, P; Child, F; Cho, A; French, LE; Gennery, AR; Gniadecki, R; Gollnick, HPM; Guenova, E; Jaksch, P; Jantschitsch, C; Klemke, C; Ludvigsson, J; Papadavid, E; Scarisbrick, J; Schwarz, T; Stadler, R; Wolf, P; Zic, J; Zouboulis, C; Zuckermann, A; Greinix, H
European dermatology forum - updated guidelines on the use of extracorporeal photopheresis 2020 - part 1.
J Eur Acad Dermatol Venereol. 2020;
Doi: 10.1111/jdv.16890
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Loper, K; Sugrue, MW; Raval, JS; Schwartz, JY; Land, K; Koh, M; Mengling, T; Greinix, H; Halter, JP; Celluzzi, CM; Chaudhri, M
Adverse event reporting for cellular therapy products: Current status and future directions.
Transfusion. 2020; 60(12):2815-2827
Doi: 10.1111/trf.16062
Web of Science
PubMed
FullText
FullText_MUG
** Penack, O; Peczynski, C; van der Werf, S; Finke, J; Ganser, A; Schoemans, H; Pavlu, J; Niittyvuopio, R; Schroyens, W; Kaynar, L; Blau, IW; van der Velden, WJFM; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Pascual-Cascon, MJ; Moreira, MC; Clausen, J; Greinix, H; Duarte, RF; Basak, GW
Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT - A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party.
Front Immunol. 2020; 11:586-586
Doi: 10.3389/fimmu.2020.00586
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Tomaszewska, A; Jagasia, M; Beohou, E; van der Werf, S; Blaise, D; Kanfer, E; Milpied, N; Reményi, P; Ciceri, F; Bourhis, JH; Chevallier, P; Solano, C; Socié, G; Bruno, B; Rambaldi, A; Castagna, L; Kröger, N; Corradini, P; Afanasyev, B; Ladetto, M; Niederwieser, D; Scheid, C; Sengeloev, H; Kroschinsky, F; Yakoub-Agha, I; Schoemans, H; Koenecke, C; Penack, O; Perić, Z; Greinix, H; Duarte, RF; Basak, GW
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell Malignancies.
FRONT IMMUNOL. 2020; 11(4): 613954-613954.
Doi: 10.3389/fimmu.2020.613954
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT
The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833
Doi: 10.1007/s12253-020-00864-6
Web of Science
PubMed
FullText
FullText_MUG
** Zebisch, A; Winter, G; Kashofer, K; Hatzl, S; Uhl, B; Wurm, S; Wölfler, A; Greinix, HT; Hoefler, G; Sill, H
The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2020; 55(7):1502-1505
Doi: 10.1038/s41409-019-0691-1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Crossland, RE; Perutelli, F; Bogunia-Kubik, K; Mooney, N; Milutin Gašperov, N; Pučić-Baković, M; Greinix, H; Weber, D; Holler, E; Pulanić, D; Wolff, D; Dickinson, AM; Inngjerdingen, M; Grce, M
Potential Novel Biomarkers in Chronic Graft-Versus-Host Disease.
Front Immunol. 2020; 11(2):602547-602547
Doi: 10.3389/fimmu.2020.602547
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT
Role of CAR-T cell therapy in B-cell acute lymphoblastic leukemia.
MEMO-MAG EUR MED ONC. 2020; 13(1): 36-42.
Doi: 10.1007/s12254-019-00541-8
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Muhsen, IN; Hashmi, SK; Niederwieser, D; Kroeger, N; Agrawal, S; Pasquini, MC; Atsuta, Y; Ballen, KK; Seber, A; Saber, W; Kharfan-Dabaja, MA; Rasheed, W; Okamoto, S; Khera, N; Wood, WA; Koh, MBC; Greinix, H; Kodera, Y; Szer, J; Horowitz, MM; Weisdorf, D; Aljurf, M
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.
Bone Marrow Transplant. 2020; 55(4):698-707
Doi: 10.1038/s41409-019-0658-2
Web of Science
PubMed
FullText
FullText_MUG
** Penack, O; Marchetti, M; Ruutu, T; Aljurf, M; Bacigalupo, A; Bonifazi, F; Ciceri, F; Cornelissen, J; Malladi, R; Duarte, RF; Giebel, S; Greinix, H; Holler, E; Lawitschka, A; Mielke, S; Mohty, M; Arat, M; Nagler, A; Passweg, J; Schoemans, H; Socie, G; Solano, C; Vrhovac, R; Zeiser, R; Kroger, N; Basak, GW
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation.
LANCET HAEMATOL. 2020; 7(2): E157-E167.
Doi: 10.1016/S2352-3026(19)30256-X
Web of Science
FullText
FullText_MUG
** Muhsen, IN; Hashmi, SK; Niederwieser, D; Kroeger, N; Agrawal, S; Pasquini, MC; Atsuta, Y; Ballen, KK; Seber, A; Saber, W; Kharfan-Dabaja, MA; Rasheed, W; Okamoto, S; Khera, N; Wood, WA; Koh, MBC; Greinix, H; Kodera, Y; Szer, J; Horowitz, MM; Weisdorf, D; Aljurf, M
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries.
Bone Marrow Transplant. 2020; 55(4):837-837
Doi: 10.1038/s41409-019-0714-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lelas, A; Langer, R; Rittenschober, M; Desnica, L; Greinix, H; Dickinson, A; Inngjerdingen, M; Lawitschka, A; Vrhovac, R; Pulanic, D; Klein, S; Middeke, JM; Edinger, M; Wolff, D
Incidence of Chronic graft-versus-host Disease - Results from a Prospective Multicentre Analysis of 2 Cohorts.
BONE MARROW TRANSPL. 2020; 55(SUPPL 1):336-337.
[Oral Communication]
Web of Science
** Sormann, S; Pasteiner, W; Kahangire, DA; Greinix, H
Outcomes of relapsed/refractory multiple myeloma patients receiving carfilzomib-based therapy in routine practice; results of a single-centre Austrian registry.
ONCOL RES TREAT. 2020; 43(SUPPL 4):115-115.
[Poster]
Web of Science
** Toenges, R; Edinger, M; Bug, G; Lawitschka, A; Greinix, H; Halter, J; Arends, J; Ayuk, F; Klein, S; Middeke, JM; Wagner-Drouet, E; Hilgendorf, I; Baumgartner, A; Wolff, D
Current Practice in Nutrition after Allogeneic Hematopoietic Stem Cell Transplantation in Austria, Germany and Switzerland.
BONE MARROW TRANSPL. 2020; 55(SUPPL 1):604-605.
[Oral Communication]
Web of Science
** Hatzl, S; Eisner, F; Schilcher, G; Kreuzer, P; Gornicec, M; Eller, P; Brodmann, M; Schlenke, P; Stradner, MH; Krause, R; Greinix, H; Schulz, E
Response to "COVID-19 in persons with haematological cancers".
Leukemia. 2020; 34(8):2265-2270
Doi: 10.1038/s41375-020-0914-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Mader, JK; Holzgruber, J; Trummer, C; Schwetz, V; Pandis, M; Pferschy, PN; Greinix, H; Tripolt, NJ; Pieber, TR; Zebisch, A; Sill, H; Wölfler, A; Sourij, H
Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial.
J Diabetes Investig. 2019; 10(2):339-342
Doi: 10.1111/jdi.12919
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Baldomero, H; Aljurf, M; Zaidi, SZA; Hashmi, SK; Ghavamzadeh, A; Elhaddad, A; Hamladji, RM; Ahmed, P; Torjemane, L; Abboud, M; Tbakhi, A; Khabori, MA; El Quessar, A; Bazuaye, N; Bekadja, MA; Adil, S; Fahmy, O; Ramzi, M; Ibrahim, A; Alseraihy, A; Ben Abdejalil, N; Sarhan, M; Huneini, MA; Mahmal, L; ElSolh, H; Hussain, F; Nassar, A; Al-Hashmi, H; Hamidieh, AA; Pasquini, M; Kodera, Y; Kröger, N; Mohty, M; Jaimovich, G; Rolon, JM; Paulson, K; Greinix, H; Weisdorf, D; Horowitz, M; Nunez, J; Gratwohl, A; Passweg, J; Koh, M; Szer, J; Niederwieser, D; Novitzky, N; East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT)
Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends.
BONE MARROW TRANSPL. 2019; 54(3): 402-417.
Doi: 10.1038/s41409-018-0275-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jagasia, M; Scheid, C; Socié, G; Ayuk, FA; Tischer, J; Donato, ML; Bátai, Á; Chen, H; Chen, SC; Chin, T; Boodée, H; Mitri, G; Greinix, HT
Randomized controlled study of ECP with methoxsalen as first-line treatment of patients with moderate to severe cGVHD.
BLOOD ADV. 2019; 3(14): 2218-2229.
Doi: 10.1182/bloodadvances.2019000145
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kröger, N; Eikema, DJ; Köster, L; Beelen, D; de Wreede, LC; Finke, J; Koenecke, C; Niederwieser, D; Bornhäuser, M; Schoenland, S; Potter, V; Wolschke, C; Maertens, J; Theobald, M; Kobbe, G; Itälä-Remes, M; Wulf, G; Kahls, P; Forcade, E; Greinix, H; Masszi, T; Yakoub-Agha, I; Chalandon, Y; Robin, M; Chronic Malignancies Working Party of the European Society for Blood Marrow Transplantation
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemia.
BRIT J HAEMATOL. 2019; 185(4): 725-732.
Doi: 10.1111/bjh.15819
Web of Science
PubMed
FullText
FullText_MUG
** Lawitschka, A; Gueclue, ED; Januszko, A; Körmöczi, U; Rottal, A; Fritsch, G; Bauer, D; Peters, C; Greinix, HT; Pickl, WF; Kuzmina, Z
National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
FRONT IMMUNOL. 2019; 10: 1879-1879.
Doi: 10.3389/fimmu.2019.01879
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Moiseev, IS; Tsvetkova, T; Aljurf, M; Alnounou, RM; Bogardt, J; Chalandon, Y; Drokov, MY; Dvirnyk, V; Faraci, M; Friis, LS; Giglio, F; Greinix, HT; Kornblit, BT; Koelper, C; Koenecke, C; Lewandowski, K; Niederwieser, D; Passweg, JR; Peczynski, C; Penack, O; Peric, Z; Piekarska, A; Ronchi, PE; Rovo, A; Rzepecki, P; Scuderi, F; Sigrist, D; Siitonen, SM; Stoelzel, F; Sulek, K; Tsakiris, DA; Wilkowojska, U; Duarte, RF; Ruutu, T; Basak, GW
Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.
BONE MARROW TRANSPL. 2019; 54(7): 1022-1028.
Doi: 10.1038/s41409-018-0374-3
Web of Science
PubMed
FullText
FullText_MUG
** Pansy, K; Feichtinger, J; Ehall, B; Uhl, B; Sedej, M; Roula, D; Pursche, B; Wolf, A; Zoidl, M; Steinbauer, E; Gruber, V; Greinix, HT; Prochazka, KT; Thallinger, GG; Heinemann, A; Beham-Schmid, C; Neumeister, P; Wrodnigg, TM; Fechter, K; Deutsch, AJ
The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.
Int J Mol Sci. 2019; 20(19):
Doi: 10.3390/ijms20194740
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Scheidl, S; Zinke-Cerwenka, W; Flick, H; Gaal, S; Avian, A; Greinix, H; Olschewski, H
Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation.
Biol Blood Marrow Transplant. 2019; 25(1):129-136
Doi: 10.1016/j.bbmt.2018.07.036
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Hilgendorf, I; Wagner-Drouet, E; Jedlickova, Z; Ayuk, F; Zeiser, R; Schäfer-Eckart, K; Gerbitz, A; Stadler, M; Klein, S; Middeke, JM; Lawitschka, A; Winkler, J; Halter, J; Holler, E; Kobbe, G; Stelljes, M; Ditschkowski, M; Greinix, H
Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland.
BIOL BLOOD MARROW TR. 2019; 25(7): 1450-1455.
Doi: 10.1016/j.bbmt.2019.03.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Richtig, G; Ramelyte, E; Koch, L; Greinix, H; Ferrone, S; Dummer, R; Richtig, E
Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
J Eur Acad Dermatol Venereol. 2019; 33(10):e381-e383-e381-e383
Doi: 10.1111/jdv.15675
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aljurf, M; Weisdorf, D; Alfraih, F; Szer, J; Müller, C; Confer, D; Hashmi, S; Kröger, N; Shaw, BE; Greinix, H; Kharfan-Dabaja, MA; Foeken, L; Seber, A; Ahmed, S; El-Jawahri, A; Al-Awwami, M; Atsuta, Y; Pasquini, M; Hanbali, A; Alzahrani, H; Okamoto, S; Gluckman, E; Mohty, M; Kodera, Y; Horowitz, M; Niederwieser, D; El Fakih, R
"Worldwide Network for Blood & Marrow Transplantation (WBMT) special article, challenges facing emerging alternate donor registries".
BONE MARROW TRANSPL. 2019; 54(8): 1179-1188.
Doi: 10.1038/s41409-019-0476-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aljurf, M; Weisdorf, D; Hashmi, S; Nassar, A; Gluckman, E; Mohty, M; Rizzo, D; Pasquini, M; Hamadani, M; Saber, W; Hari, P; Kharfan-Dabaja, M; Majhail, N; Gerges, U; Hamidieh, AA; Hussain, F; Elhaddad, A; Mahmoud, HK; Tbakhi, A; Othman, TB; Hamladji, RM; Bekadja, MA; Ahmed, P; Bazarbachi, A; Adil, S; Alkindi, S; Ladeb, S; Dennison, D; Patel, M; Lu, P; Quessar, AE; Okamoto, S; Atsuta, Y; Alhejazi, A; Ayas, MF; Ahmed, SO; Novitzky, N; Srivastava, A; Seber, A; Solh, HE; Ghavamzadeh, A; Confer, D; Kodera, Y; Hildegard, G; Szer, J; Horowitz, MM; Niederwieser, D
Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Stem Cell Transplantation Program in Countries with Limited Resources, Part II: Clinical, Technical, and Socioeconomic Considerations.
Biol Blood Marrow Transplant. 2019; 25(12):2330-2337
Doi: 10.1016/j.bbmt.2019.04.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hatzl, S; Greinix, HT; Kreuzer, P; Schulz, E; Neumeister, P; Scherr, D
A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient-a case report
MEMO-MAG EUR MED ONC. 2019; 12(3): 269-271.
Doi: 10.1007/s12254-019-0514-5
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Bohm, A; Lindner, B; Rabitsch, W; Kalhs, P; Worel, N; Clausen, J; Nachbaur, D; Neumeister, P; Panny, M; Keil, F; Russ, G; Eder, S; Isak, E; Zojer, N; Burger, S; Greinix, H
POSTTRANSPLANT OUTCOMES IN ALLOGENEIC AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN AUSTRIA IN COMPARISON TO THE EBMT BENCHMARK: A RETROSPECTIVE ANALYSIS OF THE AUSTRIAN SCT REGISTRY (ASCTR) 2000-2017
TRANSPL INT. 2019; 32: 20-20.
[Oral Communication]
Web of Science
** Dietrich, S; Finel, H; Lu, JJ; Boumendil, A; Sengeloev, H; Socie, G; Labussiere-wallet, H; Maury, S; Cornelissen, J; Chevallier, P; Colin, M; Greinix, H; Heinicke, T; Kanz, L; Beelen, D; Meijer, E; Schmid, C; Martin, H; Michel, G; Castagna, L; Schmeid, C; Schafer, K; Tsoulkani, A; Bittenbring, J; Finke, J; Koc, Y; Nagler, A; Mohty, M; Robinson, S; Dreger, P; Montoto, S
Myeloablative conditioning may contribute to disease control after stem cell transplantation in blastic plasmacytoid dentric cell neoplasia
BONE MARROW TRANSPL. 2019; 54: 108-109.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Oral Communication]
Web of Science
** Lindahl, C; Unterluggauer, J; Pansy, K; Uhl, B; Prochazka, K; Greinix, H; Weniger, M; Kuppers, R; Beham-Schmid, C; Neumeister, P; Haybaeck, J; Deutsch, A
Dysregulated eukaryotic initiation factors may impact on the pathogenesis of primary central nervous system lymphomas
ONCOL RES TREAT. 2019; 42: 82-82.
[Poster]
Web of Science
** Lindner, B; Greinix, H
Ambiguities in data reporting - multiple answer option for causes of death as hinderance for data analysis
BONE MARROW TRANSPL. 2019; 54: 676-677.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Poster]
Web of Science
** Pansy, K; Fechter, K; Kargl, J; Wenzl, K; Prochazka, K; Greinix, H; Haybaeck, J; Prokesch, A; Beham-Schmid, C; Feichtinger, J; Neumeister, P; Deutsch, A
Nr4a1 is implicated in the regulation of immune checkpoints in aggressive lymphomas
ONCOL RES TREAT. 2019; 42: 135-135.
[Oral Communication]
Web of Science
** Penack, O; Peczynski, C; van der Werf, S; Mohty, M; Yakoub-Agha, I; Montoto, S; Finke, J; Ganser, A; Schoemans, H; Apperley, J; Niittyvuopio, R; Schroyens, W; Unal, A; Gerbitz, A; Schaap, M; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Cascon, MP; Clausen, J; Greinix, H; Duarte, R; Basak, G
Association of uric acid levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party
BONE MARROW TRANSPL. 2019; 54: 296-297.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Oral Communication]
Web of Science
** Penack, O; Peczynski, C; van der Werf, S; Mohty, M; Yakoub-Agha, I; Montoto, S; Finke, J; Ganser, A; Schoemans, H; Apperley, J; Niittyvuopio, R; Schroyens, W; Unal, A; Gerbitz, A; Schaap, M; Sierra, J; Cortelezzi, A; Wulf, G; Turlure, P; Rovira, M; Ozkurt, Z; Cascon, MP; Clausen, J; Greinix, H; Duarte, R; Basak, G
Association of serum ferritin levels before start of conditioning with mortality after alloSCT - a prospective, non-interventional study of the EBMT transplant complication working party
BONE MARROW TRANSPL. 2019; 54: 238-239.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Oral Communication]
Web of Science
** Spindelbock, W; Huber-Krassnitzer, B; Uhl, B; Gorkiewicz, G; Greinix, H; Hogenauer, C; Neumeister, P
Treatment of acute refractory gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2019; 54: 294-295.-45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT); MAR 24-27, 2019; Frankfurt, GERMANY.
[Poster]
Web of Science
** Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A
Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83.
[Poster]
Web of Science
** Antlanger, M; Dust, T; Reiter, T; Böhm, A; Lamm, WW; Gornicec, M; Willenbacher, E; Nachbaur, D; Weger, R; Rabitsch, W; Rasoul-Rockenschaub, S; Worel, N; Lechner, D; Greinix, H; Keil, F; Gisslinger, H; Agis, H; Krauth, MT
Impact of renal impairment on outcomes after autologous stem cell transplantation in multiple myeloma: a multi-center, retrospective cohort study.
BMC CANCER. 2018; 18(1): 1008-1008.
Doi: 10.1186/s12885-018-4926-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Steinbauer, E; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, HT; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, AJA
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favourable cancer specific survival.
Sci Rep. 2018; 8(1):14528-14528
Doi: 10.1038/s41598-018-32972-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lenczuk, D; Zinke-Cerwenka, W; Greinix, H; Wölfler, A; Prattes, J; Zollner-Schwetz, I; Valentin, T; Lin, TC; Meinitzer, A; Hoenigl, M; Krause, R
Antifungal Prophylaxis with Posaconazole Delayed-Release Tablet and Oral Suspension in a Real-Life Setting: Plasma Levels, Efficacy, and Tolerability.
Antimicrob Agents Chemother. 2018; 62(6):
Doi: 10.1128/AAC.02655-17
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Norden, J; Pearce, KF; Irving, JAE; Collin, MP; Wang, XN; Wolff, D; Kolb, HJ; Socie, G; Kuzmina, Z; Greinix, H; Holler, E; Rocha, V; Gluckman, E; Hromadnikova, I; Dickinson, AM
The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation.
Int J Immunogenet. 2018; 13(8):
Doi: 10.1111/iji.12380
Web of Science
PubMed
FullText
FullText_MUG
** Schoemans, HM; Goris, K; Van Durm, R; Fieuws, S; De Geest, S; Pavletic, SZ; Im, A; Wolff, D; Lee, SJ; Greinix, H; Duarte, RF; Poiré, X; Selleslag, D; Lewalle, P; Kerre, T; Graux, C; Baron, F; Maertens, JA; Dobbels, F; EBMT Transplantation Complications Working party
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trial.
Haematologica. 2018; 103(10):1698-1707
Doi: 10.3324/haematol.2018.190777
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schoemans, HM; Lee, SJ; Ferrara, JL; Wolff, D; Levine, JE; Schultz, KR; Shaw, BE; Flowers, ME; Ruutu, T; Greinix, H; Holler, E; Basak, G; Duarte, RF; Pavletic, SZ; EBMT (European Society for Blood and Marrow Transplantation) Transplant Complications Working Party and the “EBMT−NIH (National Institutes of Health)−CIBMTR (Center for International Blood and Marrow Transplant Research) GvHD Task Force”
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
Bone Marrow Transplant. 2018; 53(11):1401-1415
Doi: 10.1038/s41409-018-0204-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Greinix, H; Lee, SJ; Gooley, T; Paczesny, S; Pavletic, S; Hakim, F; Malard, F; Jagasia, M; Lawitschka, A; Hansen, JA; Pulanic, D; Holler, E; Dickinson, A; Weissinger, E; Edinger, M; Sarantopoulos, S; Schultz, KR
Biomarkers in chronic graft-versus-host disease: quo vadis?
Bone Marrow Transplant. 2018; 53(7):832-837
Doi: 10.1038/s41409-018-0092-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Lehner, E; Führer, H; Kalhs, P; Rabitsch, W; Mitterbauer, M; Hopfinger, G; Greinix, HT
Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?
TRANSFUSION. 2018; 58(4): 1045-1053.
Doi: 10.1111/trf.14506
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prochazka, KT; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Abdyli, L; Greinix, H; Pichler, M; Neumeister, P
Immunohistochemical double hit score enhances NCCN-IPI and is associated with detrimental outcomes in refractory or relapsing patients with diffuse large B cell lymphoma.
Br J Haematol. 2018; 183(1):142-146
Doi: 10.1111/bjh.14912
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schoemans, HM; Goris, K; Van Durm, R; Vanbrabant, K; De Geest, S; Maertens, J; Wolff, D; Greinix, H; Ruutu, T; Pavletic, SZ; Im, A; Lee, SJ; Basak, GW; Duarte, RF; Dobbels, F; Complications and Quality of Life Working Party of the EBMT
Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress.
Bone Marrow Transplant. 2018; 53(4):490-494
Doi: 10.1038/s41409-017-0017-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kuhl, R; Meier, S; Baeurle, M; Wolff, D; Greinix, H; Lawitschka, A; Halter, J; Bertz, H; Hilgendorf, I
Sport Therapy and Physiotherapy for Treatment of cGvHD
PHYS MED REHAB KUROR. 2018; 28(4): 224-230.
Doi: 10.1055/a-0626-7317
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Dressel, R; Greinix, HT; Holler, E; Dickinson, AM
Editorial: Cellular Therapies: Past, Present and Future.
Front Immunol. 2018; 9(5):1966-1966
Doi: 10.3389/fimmu.2018.01966
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bergmann, TC; Pursche, B; Greinix, H; Neumeister, P; Deutsch, A; Prochazka, K
Overexpression of miR199a and miR497 regulates Nf-kappa B and B-cell receptor signalling in diffuse large B-cell lymphoma (DLBCL)
ONCOL RES TREAT. 2018; 41: 81-82.
[Poster]
Web of Science
** Brauchart, T; Bergmann, TC; Pansy, K; Fechter, K; Greinix, H; Neumeister, P; Deutsch, A
Starvation increases the anticancer activity of Ibrutinib in ABC-DLBCL cells in vitro
ONCOL RES TREAT. 2018; 41: 81-81.-DGHO; Oktober 2018; wien.
[Poster]
Web of Science
** Caballero, MD; Cwynarski, K; Dreger, P; Thieblemont, C; Vandenberghe, P; Zinzani, PL; Muller, A; Greinix, H; Avivi, I; Enblad, G; Locke, FL; Yang, Y; Brock, K; Cheng, P; Kersten, MJ
ZUMA-7: RANDOMIZED PHASE 3 ESSAY OF AXICABTAGEN CILOLEUCEL (AXI-CEL) VS STANDARD TREATMENT (SOC) IN PATIENTS WITH LYMPHOMA B DIFFUSE OF LARGE CELLS IN RECYCLED/REFRACTORY (R/R DLBCL)
HAEMATOLOGICA. 2018; 103: 359-359.-60th National Congress of the Spanish-Society-of-Hematology-and-Hemotherapy; OCT 11-13, 2018; Granada, SPAIN.
[Poster]
Web of Science
** Deutsch, A; Bergmann, TC; Fechter, K; Prochazka, K; Weniger, MA; Kuppers, R; Unterluggauer, JJ; Greinix, H; Beham-Schmid, C; Neumeister, P
Low NR4A1 expression is associated with an up-regulation of immune checkpoints and their ligands in DLBCL
ONCOL RES TREAT. 2018; 41: 82-82.
[Poster]
Web of Science
** Fechter, K; Feichtinger, J; Prochazka, K; Unterluggauer, JJ; Pansy, K; Pichler, M; Haybaeck, J; Prokesch, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Thallinger, GG; Deutsch, A
Cytoplasmic location of NR4A1 in aggressive lymphomas is associated with a favorable cancer specific survival
ONCOL RES TREAT. 2018; 41: 82-83.
[Poster]
Web of Science
** Fechter, K; Pansy, K; Hauer, A; Kargl, J; Krogsdam, A; Greinix, H; Beham-Schmid, C; Neumeister, P; Prokesch, A; Deutsch, A
Nr4a1 has as a tumor suppressive function in Myc-driven lymphomagenesis by altering the tumor microenvironment
ONCOL RES TREAT. 2018; 41: 82-82.-DHGO; Oktober 2018; Wien.
[Poster]
Web of Science
** Greinix, HT; Eikema, DJ; Koster, L; Penack, O; Yakoub-Agha, I; Montoto, S; Chabannon, C; Styczynski, J; Nagler, A; Robin, M; Robinson, S; Chalandon, Y; Mikulska, M; Schonland, S; Peric, Z; Ruggeri, A; Lanza, F; Mohty, M; Basak, GW; Nicolaus, K
Incidence of Acute Graft-Versus-Host Disease and Survival after Allogeneic Hematopoietic Cell Transplantation over Time: A Study from the Transplant Complications and Chronic Malignancies Working Party of the EBMT
BLOOD. 2018; 132:
Doi: 10.1182/blood-2018-99-111764
Web of Science
FullText
FullText_MUG
** Meier, S; Kuhl, R; Baurle, M; Wolff, D; Greinix, H; Lawitschka, A; Halter, J; Bertz, H; Hilgendorf, I
Exercise therapy for treatment of chronic graft-versus-host disease: recommendations of the German-Austrian-Swiss GvHD consortium
ONCOL RES TREAT. 2018; 41: 64-64.
[Oral Communication]
Web of Science
** Pansy, K; Fechter, K; Unterluggauer, JJ; Weniger, MA; Kuppers, R; Greinix, H; Prochazka, K; Karbiener, M; Neumeister, P; Deutsch, A
Reduced NR4A1 levels are associated with high expression of miR-15a and miR-15a*in DLBCL
ONCOL RES TREAT. 2018; 41: 81-81.
[Poster]
Web of Science
** Schoemans, HM; Goris, K; Van Durm, R; Vanbrabant, K; De Geest, S; Pavletic, SZ; Im, A; Wolff, D; Lee, SJ; Greinix, H; Duarte, RF; Poire, X; Selleslag, D; Lewalle, P; Kerre, T; Graux, C; Baron, F; Maertens, JA; Dobbels, F
A National Multi-Center Randomized Study to Assess the Accuracy, Reliability, and User Satisfaction of the Ebmt Gvhd App in Graft Versus Host Disease Assessment
BIOL BLOOD MARROW TR. 2018; 24(3):S191-S191.-Blood and Marrow Transplantion Tandem Meetings of the Center-for-International-Blood-and-Marrow-Transplant-Research (CIBMTR) / American-Society-for-Blood-and-Marrow-Transplantation (ASBMT); FEB 21-25, 2018; Salt Lake City, UT.
Doi: 10.1016/j.bbmt.2017.12.147
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Schukoff, T; Winkler, S; Unterluggauer, JJ; Fechter, K; Greinix, H; Beham-Schmid, C; Schaider, H; Deutsch, A; Prochazka, K; Neumeister, P
Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma
ONCOL RES TREAT. 2018; 41: 50-50.
[Poster]
Web of Science
** Sormann, S; Greinix, H
Role of TPO agonists in the chronic immune thrombocytopenia treatment algorithm - a single-center registry analysis
ONCOL RES TREAT. 2018; 41: 105-106.
[Poster]
Web of Science
** Wolff, D; Hilgendorf, I; Wagner-Drouet, EM; Jedlickova, Z; Middeke, JM; Ayuk, FA; Zeiser, R; Lawitschka, A; Halter, J; Klein, SA; Holler, E; Greinix, H
Changes in immunosuppressive treatment of chronic graft-versus-host disease - comparison of 2 surveys within hematopoietic stem cell transplant centers in Germany, Austria and Switzerland performed in 2009 and 2018
ONCOL RES TREAT. 2018; 41: 119-119.
[Oral Communication]
Web of Science
** Crossland, RE; Norden, J; Juric, MK; Green, K; Pearce, KF; Lendrem, C; Greinix, HT; Dickinson, AM
Expression of Serum microRNAs is Altered During Acute Graft-versus-Host Disease.
Front Immunol. 2017; 8(5):308-308
Doi: 10.3389/fimmu.2017.00308
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Crossland, RE; Norden, J; Juric, MK; Pearce, KF; Lendrem, C; Bibby, LA; Collin, M; Greinix, HT; Dickinson, AM
Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93(star) As Biomarkers for Acute Graft-wersus-Host Disease
FRONT IMMUNOL. 2017; 8: 1446
Doi: 10.3389/fimmu.2017.01446
[OPEN ACCESS]
Web of Science
FullText
FullText_MUG
** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P
NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386
Doi: 10.1158/0008-5472.CAN-16-2320
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gratwohl, A; Sureda, A; Cornelissen, J; Apperley, J; Dreger, P; Duarte, R; Greinix, HT; Mc Grath, E; Kroeger, N; Lanza, F; Nagler, A; Snowden, JA; Niederwieser, D; Brand, R
Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.
Leukemia. 2017; 31(8):1752-1759
Doi: 10.1038/leu.2017.79
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Magina, KN; Pregartner, G; Zebisch, A; Wölfler, A; Neumeister, P; Greinix, HT; Berghold, A; Sill, H
Cytarabine dose in the consolidation treatment of AML: a systematic review and meta-analysis.
Blood. 2017; 130(7): 946-948.
Doi: 10.1182/blood-2017-04-777722
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pulewka, K; Wolff, D; Herzberg, PY; Greinix, H; Heussner, P; Mumm, FHA; von Harsdorf, S; Rieger, K; Hemmati, P; Hochhaus, A; Hilgendorf, I
Physical and psychosocial aspects of adolescent and young adults after allogeneic hematopoietic stem-cell transplantation: results from a prospective multicenter trial.
J Cancer Res Clin Oncol. 2017; 143(8):1613-1619
Doi: 10.1007/s00432-017-2424-4
Web of Science
PubMed
FullText
FullText_MUG
** Ruutu, T; Gratwohl, A; Niederwieser, D; de Witte, T; van der Werf, S; van Biezen, A; Mohty, M; Kröger, N; Rambaldi, A; McGrath, E; Sureda, A; Basak, G; Greinix, H; Duarte, RF
The EBMT-ELN working group recommendations on the prophylaxis and treatment of GvHD: a change-control analysis.
Bone Marrow Transplant. 2017; 52(3):357-362
Doi: 10.1038/bmt.2016.298
Web of Science
PubMed
FullText
FullText_MUG
** Stauber, MN; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wölfler, A
Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2017; 23(7):1186-1192
Doi: 10.1016/j.bbmt.2017.03.010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Weissinger, EM; Human, C; Metzger, J; Hambach, L; Wolf, D; Greinix, HT; Dickinson, AM; Mullen, W; Jonigk, D; Kuzmina, Z; Kreipe, H; Schweier, P; Böhm, O; Türüchanow, I; Ihlenburg-Schwarz, D; Raad, J; Durban, A; Schiemann, M; Könecke, C; Diedrich, H; Holler, E; Beutel, G; Krauter, J; Ganser, A; Stadler, M
The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation.
Leukemia. 2017; 31(3):654-662
Doi: 10.1038/leu.2016.259
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Fritsch, G; Agis, H; Böhm, A; Engelich, G; Leitner, GC; Geissler, K; Gleixner, K; Kalhs, P; Buxhofer-Ausch, V; Keil, F; Kopetzky, G; Mayr, V; Rabitsch, W; Reisner, R; Rosskopf, K; Ruckser, R; Zoghlami, C; Zojer, N; Greinix, HT
Plerixafor as preemptive strategy results in high success rates in autologous stem cell mobilization failure.
J Clin Apher. 2017; 32(4):224-234
Doi: 10.1002/jca.21496
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Kremser, S; Mader, JK; Zinke-Cerwenka, W; Greinix, H; Tripolt, NJ; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Sourij, H; Wölfler, A
Hyperglycaemia within the first month after allogeneic haematopoietic stem-cell transplantation is an independent risk factor for overall survival in patients with acute myeloid leukaemia.
Diabetes Metab. 2017; 43(6):560-562
Doi: 10.1016/j.diabet.2017.02.001
Web of Science
PubMed
FullText
FullText_MUG
** Hilgendorf, I; Greinix, H; Halter, J; Lawitschka, A; Wolff, D
Vaccination of allogeneic hematopoietic stem cell transplant recipients-what should be considered?
Ann Hematol. 2017; 96(4): 701-702.
Doi: 10.1007/s00277-017-2922-0
Web of Science
PubMed
FullText
FullText_MUG
** Spindelboeck, W; Schulz, E; Uhl, B; Kashofer, K; Aigelsreiter, A; Zinke-Cerwenka, W; Mulabecirovic, A; Kump, PK; Halwachs, B; Gorkiewicz, G; Sill, H; Greinix, H; Högenauer, C; Neumeister, P
Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease.
Haematologica. 2017; 102(5):e210-e213-e210-e213
Doi: 10.3324/haematol.2016.154351
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hashmi, SK; Srivastava, A; Rasheed, W; Adil, S; Wu, T; Jagasia, M; Nassar, A; Hwang, WYK; Hamidieh, AA; Greinix, HT; Pasquini, MC; Apperley, JF; Aljurf, M
Cost and quality issues in establishing hematopoietic cell transplant program in developing countries.
Hematol Oncol Stem Cell Ther. 2017; 10(4):167-172
Doi: 10.1016/j.hemonc.2017.05.017
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Aberer, F; Holzgruber, J; Tripolt, NJ; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Pieber, TR; Wölfler, A; Sourij, H
Efficacy and safety of an insulin decision support system in the treatment of steroid hyperglycaemia in patients with graft-versus- host-disease: a randomised pilot trial.
Diabetologia. 2017; 60(S1):S323-S324.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL.
[Poster]
Web of Science
** Anne, D; Jean, N; Kralj, JM; Kile, G; Kim, P; Clare, L; Hildegard, G; Rachel, C
Expression of serum MicroRNAs is dysregulated during acute graft versus host disease
BONE MARROW TRANSPL. 2017; 52: S486-S486.
Web of Science
** Deutsch, A; Pursche, B; Ehall, B; Zoidl, M; Fechter, K; Steinbauer, E; Sedej, M; Greinix, H; Prochazka, K; Wrodnigg, T; Beham-Schmid, C; Neumeister, P;
CXCR4 AND CXCL12 ARE IMPLICATED IN BONE MARROW INFILTRATION PROCESS OF AGGRESSIVE B CELL LYMPHOMAS AND THEIR INHIBITION SUPPRESSES LYMPHOMA CELL GROWTH IN VITRO.
HAEMATOLOGICA. HAEMATOLOGICA102: 572-572. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 22nd Congress of the European-Hematology-Association, Madrid, SPAIN, JUN 22-25, 2017)
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
LOSS OF NR4A1 ACCELERATES MYC-DRIVEN LYMPHOMAGENESIS ACCOMPANIED BY OVEREXPRESSION OF GENES INVOLVED IN IMMUNOREGULATION.
HAEMATOLOGICA. 2017; 102: 560-561.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN.
[Oral Communication]
Web of Science
** Fechter, K; Wenzl, K; Prochazka, K; Pansy, K; Pursche, B; Greinix, H; Beham-Schmid, C; Neumeister, P; Deutsch, A
Loss of Nr4a1 accelerates Myc-driven lymphomagenesis and alters the composition of immune cells in the tumor microenvironment
ONCOL RES TREAT. 2017; 40: 108-108.
[Poster]
Web of Science
** Hilgendorf, I; Greinix, H; Halter, J; Ayuk, F; Wagner, EM; Lindner, B; Gleich, S; Hochhaus, A; Wolff, D
The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation
ONCOL RES TREAT. 2017; 40: 286-286.
[Oral Communication]
Web of Science
** Hilgendorf, L; Pulewka, K; Herzberg, PY; Greinix, H; Heussner, P; Mumm, F; von Harsdorf, S; Rieger, K; Hemmati, P; Holler, E; Hochhaus, A; Wolff, D
Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs
ONCOL RES TREAT. 2017; 40: 230-231.
[Oral Communication]
Web of Science
** Jagasia, M; Beohou, E; van der Werf, S; Niederwieser, D; Dreger, P; Meijer, E; Chevallier, P; Sengeloev, H; Blaise, D; Petersen, E; Cornelissen, JJ; Ehninger, G; Gribben, J; Caballero, D; Beguin, Y; Hallek, M; Jindra, P; Fanin, R; Delage, J; Maertens, J; Gedde-Dahl, T; Montoto, S; Kroger, N; Greinix, H; Duarte, R
Addition of rituximab in reduced intensity conditioning regimens for B-cell malignancies does not influence transplant outcomes: an EBMT registry analyses
BONE MARROW TRANSPL. 2017; 52: S83-S83.
Web of Science
** Mary, DA; Jean, N; Kralj, JM; Frances, PK; Clare, L; Louis, AB; Matthew, C; Hildegard, G; Emily, CR
Serum and extracellular vesicle MicroRNAs miR-423, miR-199 and miR-93*as biomarkers for acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S509-S509.
Web of Science
** Neumeister, P; Spindelboeck, W; Zinke-Cerwenka, W; Schulz, E; Hoegenauer, C; Sill, H; Gorkiewicz, G; Kump, P; Greinix, H
Successful treatment of steroid-refractory acute gastrointestinal graft-versus-host-disease by fecal microbiota transplantation
BONE MARROW TRANSPL. 2017; 52: S232-S232.
Web of Science
** Panny, M; Prochazka, K; Holzer, K; Neumeister, P; Nosslinger, T; Rathkolb, V; Greinix, H; Keil, F
Treatment of high risk aggressive B cell lymphomas with DA EPOCH R - a retrospective analysis
ONCOL RES TREAT. 2017; 40: 69-70.
[Poster]
Web of Science
** Stauber, M; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A
Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S285-S285.
Web of Science
** Greinix, HT
Chronic GVHD: progress in salvage treatment?
Blood. 2017; 130(21):2237-2238
Doi: 10.1182/blood-2017-10-808626
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wölfler, A; Sill, H; Zebisch, A
Infections in patients with acute myeloid leukemia treated with low-intensity therapeutic regimens: Risk factors and efficacy of antibiotic prophylaxis.
Leuk Res. 2016; 42(3):47-51
Doi: 10.1016/j.leukres.2016.01.014
Web of Science
PubMed
FullText
FullText_MUG
** Bojic, M; Worel, N; Sperr, WR; Schellongowski, P; Wohlfarth, P; Schwarzinger, I; Mitterbauer-Hohendanner, G; Fischer, G; Dieckmann, KU; Lamm, W; Leiner, M; Schulenburg, A; Mitterbauer, M; Greinix, HT; Kalhs, P; Rabitsch, W
Umbilical Cord Blood Transplantation Is a Feasible Rescue Therapeutic Option for Patients Suffering from Graft Failure after Previous Hematopoietic Stem Cell Transplantation.
Oncology. 2016; 90(3):160-166
Doi: 10.1159/000443767
Web of Science
PubMed
FullText
FullText_MUG
** Doehn, JM; Winkler, A; Kuzmina, Z; Hladik, A; Greinix, H; Knapp, S; Robak, O
Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Exp Hematol. 2016; 44(10):917-923
Doi: 10.1016/j.exphem.2016.07.002
Web of Science
PubMed
FullText
FullText_MUG
** Niederwieser, D; Baldomero, H; Szer, J; Gratwohl, M; Aljurf, M; Atsuta, Y; Bouzas, LF; Confer, D; Greinix, H; Horowitz, M; Iida, M; Lipton, J; Mohty, M; Novitzky, N; Nunez, J; Passweg, J; Pasquini, MC; Kodera, Y; Apperley, J; Seber, A; Gratwohl, A
Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey.
Bone Marrow Transplant. 2016; 51(6):778-785
Doi: 10.1038/bmt.2016.18
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pearce, KF; Balavarca, Y; Norden, J; Jackson, G; Holler, E; Dressel, R; Greinix, H; Toubert, A; Gluckman, E; Hromadnikova, I; Sedlacek, P; Wolff, D; Holtick, U; Bickeböller, H; Dickinson, AM
Impact of genomic risk factors on survival after haematopoietic stem cell transplantation for patients with acute leukaemia.
Int J Immunogenet. 2016; 43(6):404-412
Doi: 10.1111/iji.12295
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Bojic, M; Wohlfarth, P; Leiner, M; Schörgenhofer, C; Kalhs, P; Schulenburg, A; Sillaber, C; Mitterbauer, M; Sperr, WR; Jäger, U; Skrabs, K; Greinix, H; Hermann, A; Lamm, W
Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis.
J Cancer Res Clin Oncol. 2016; 142(6):1307-1314
Doi: 10.1007/s00432-016-2134-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Robak, O; Kuzmina, Z; Winkler, A; Kalhs, P; Rabitsch, W; Greinix, H
Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation.
Croat Med J. 2016; 57(3):255-265
Doi: 10.3325/cmj.2016.57.255
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schoemans, H; Goris, K; Durm, RV; Vanhoof, J; Wolff, D; Greinix, H; Pavletic, S; Lee, SJ; Maertens, J; Geest, SD; Dobbels, F; Duarte, RF
Development, preliminary usability and accuracy testing of the EBMT 'eGVHD App' to support GvHD assessment according to NIH criteria-a proof of concept.
Bone Marrow Transplant. 2016; 51(8):1062-1065
Doi: 10.1038/bmt.2016.26
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schwarz, C; Lawitschka, A; Böhmig, GA; Dauber, EM; Greinix, H; Kozakowski, N; Mühlbacher, F; Berlakovich, GA; Wekerle, T
Kidney Transplantation With Corticosteroids Alone After Haploidentical HSCT From The Same Donor.
Transplantation. 2016; 100(10):2219-2221
Doi: 10.1097/TP.0000000000001213
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Styczynski, J; Tridello, G; Gil, L; Ljungman, P; Hoek, J; Iacobelli, S; Ward, KN; Cordonnier, C; Einsele, H; Socie, G; Milpied, N; Veelken, H; Chevallier, P; Yakoub-Agha, I; Maertens, J; Blaise, D; Cornelissen, J; Michallet, M; Daguindau, E; Petersen, E; Passweg, J; Greinix, H; Duarte, RF; Kröger, N; Dreger, P; Mohty, M; Nagler, A; Cesaro, S
Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
J Clin Oncol. 2016; 34(19):2212-2220
Doi: 10.1200/JCO.2015.64.2405
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Knobler, R; Greinix, HT
Extracorporeal Photopheresis
TRANSFUSIONSMEDIZIN. 2016; 6(3): 115-122.
Doi: 10.1055/s-0042-110175
Web of Science
FullText
FullText_MUG
** Gratwohl, A; Ruiz de Elvira, C; Gratwohl, M; Greinix, HT; Duarte, R; Graft-versus-Host Disease Subcommittee of the Complications and Quality of Life Working Party of the European Society for Blood and Marrow Transplantation
Gender and Graft-versus-Host Disease after Hematopoietic Stem Cell Transplantation.
BIOL BLOOD MARROW TR. 2016; 22(6): 1145-1146.
Doi: 10.1016/j.bbmt.2016.03.020
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bitan, M; van Walraven, SM; Worel, N; Ball, LM; Styczynski, J; Torrabadella, M; Witt, V; Shaw, BE; Seber, A; Yabe, H; Greinix, HT; Peters, C; Gluckman, E; Rocha, V; Halter, J; Pulsipher, MA
Determination of Eligibility in Related Pediatric Hematopoietic Cell Donors: Ethical and Clinical Considerations. Recommendations from a Working Group of the Worldwide Network for Blood and Marrow Transplantation Association.
Biol Blood Marrow Transplant. 2016; 22(1):96-103
Doi: 10.1016/j.bbmt.2015.08.017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Juric, MK; Ghimire, S; Ogonek, J; Weissinger, EM; Holler, E; van Rood, JJ; Oudshoorn, M; Dickinson, A; Greinix, HT
Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.
Front Immunol. 2016; 7(1):470-470
Doi: 10.3389/fimmu.2016.00470
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Juric, MK; Shevtsov, M; Mozes, P; Ogonek, J; Crossland, RE; Dickinson, AM; Greinix, HT; Holler, E; Weissinger, EM; Multhoff, G
B-Cell-Based and Soluble Biomarkers in Body Liquids for Predicting Acute/Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.
Front Immunol. 2016; 7(3):660-660
Doi: 10.3389/fimmu.2016.00660
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ogonek, J; Kralj Juric, M; Ghimire, S; Varanasi, PR; Holler, E; Greinix, H; Weissinger, E
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.
Front Immunol. 2016; 7(50):507-507
Doi: 10.3389/fimmu.2016.00507
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pulanić, D; Desnica, L; Vrhovac, R; Nemet, D; Wolff, D; Greinix, H; Pavletic, SZ
Chronic graft-vs-host disease in 2016: a major challenge and an opportunity.
CROAT MED J. 2016; 57(1): 1-3.
Doi: 10.3325/cmj.2016.57.1
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Mader, JK; Wolfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H
Pilot Study for Verifying the Feasibility and Efficiency of a standard Blood Glucose Control using an automated Decision Support Algorithm in the Insulin Therapy of Patients with Graft-versus-host Disease
WIEN KLIN WOCHENSCHR. 2016; 128: S407-S407.-44. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Deutsch, AJA; Rinner, B; Pichler, M; Fechter, K; Greinix, HT; Wang, CG; Beham-Schmid, C; Neumeister, P;
NR4A3 Suppresses Lymphomagenesis In Vitro and In Vivo by Induction of Similar Patterns of Pro-Apoptotic Genes like NR4A1.
BLOOD. BLOOD128: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego, CA, DEC 03-06, 2016)
Doi: 10.1182/blood.V128.22.2728.2728
Web of Science
FullText
FullText_MUG
** Hilgendorf, I; Greinix, H; Halter, J; Ayuk, F; Wagner, EM; Lindner, B; Gleich, S; Hochhaus, A; Wolff, D
The JETS-project of the German-Austrian-Swiss GVHD Consortium - a prospective study of late effects in adolescent and young adults after stem cell transplantation
ONCOL RES TREAT. 2016; 39: 286-286.
[Oral Communication]
Web of Science
** Hilgendorf, I; Pulewka, K; Herzberg, PY; Greinix, H; Heussner, P; Mumm, F; von Harsdorf, S; Rieger, K; Hemmati, P; Holler, E; Hochhaus, A; Wolff, D
Adolescent and young adults versus older adults in the setting of allogeneic stem cell transplantation - two cohorts with special needs
ONCOL RES TREAT. 2016; 39: 230-231.
[Oral Communication]
Web of Science
** Lindner, B; Rumpold, G; Gleich, S; Hilgendorf, I; Halter, J; Lawitschka, A; Ayuk, F; Schoemans, H; Greinix, H; Wolff, D
Linking MED-A-data to an external database: the GVHD-registry project
BONE MARROW TRANSPL. 2016; 51: S549-S550.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
[Poster]
Web of Science
** Macher, S; Zinke-Cerwenka, W; Posch, U; Ulrich, S; Sipurzynski, S; Greinix, H; Schlenke, P
Thrombozytenrefraktärität durch Anti-HPA 3a bei Zustand nach allogener Blutstammzelltransplantation: ein Fallbericht.
TRANSPL INT. . 2016; 29(s4):21-21.-Austrostransplant 2016; OCT 19-21, 2016; Schladming, AUSTRIA.
[Poster]
Web of Science
** Panny, M; Troppan, K; Neumeister, P; Nosslinger, T; Holzer, K; Greinix, H; Keil, F
TREATMENT OF HIGH RISK AGGRESSIVE B CELL LYMPHOMAS WITH DA EPOCH R- A RETROSPECTIVE ANALYSIS
HAEMATOLOGICA. 2016; 101: 698-698.-21st Congress of the European-Hematology-Association; JUN 09-12, 2016; Copenhagen, DENMARK.
[Poster]
Web of Science
** Schoemans, HM; Goris, K; Van Durm, R; Vanhoof, J; Greinix, DWPH; Pavletic, SZ; Lee, SJ; Maertens, JA; De Geest, S; Dobbels, F; Duarte, RF
The 'EBMT GVHD App' Improves the Accuracy of Graft-Versus-Host-Disease Assessment According to NIH Criteria Compared to Standard Practice
BIOL BLOOD MARROW TR. 2016; 22(3):S284-S284.-BMT Tandem Meetings; FEB 18-22, 2016; Honolulu, HI.
Doi: 10.1016/j.bbmt.2015.11.731
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Schwarz, C; Lawitschka, A; Bohmig, G; Dauber, E; Greinix, H; Kozakowski, N; Muhlbacher, F; Berlakovich, G; Wekerle, T
Three-Year Outcome After HSCT with Subsequent KT from the Same Haploidentical Donor without Immunosuppression.
AM J TRANSPLANT. 2016; 16: 727-727.-American Transplant Congress; JUN 11-15, 2016; Boston, MA.
[Oral Communication]
Web of Science
** Troppan, K; Beham, C; Greinix, H; Deutsch, A; Neumeister, P;
DOUBLE PROTEIN LYMPHOMA PATIENTS OF THE NON-GCB SUBTYPE HAVE AN INFERIOR PROGNOSIS WHEN TREATED WITH CHEMOIMMUNOTHERAPY.
HAEMATOLOGICA. HAEMATOLOGICA101: 396-397. PAVIA: FERRATA STORTI FOUNDATION; ( Presented at: 21st Congress of the European-Hematology-Association, Copenhagen, DENMARK, JUN 09-12, 2016)
Web of Science
** Troppan, K; Pregartner, G; Zach, V; Greinix, H; Neumeister, P
Identification of prognostic factors in patients with mature lymphoid malignancies undergoing autologous stem cell transplantation-a single center experience
BONE MARROW TRANSPL. 2016; 51: S506-S506.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
[Poster]
Web of Science
** Worel, N; Fritsch, G; Agis, H; Zojer, N; Ruckser, R; Greinix, H
A Higher Amount of More Primitive Stem Cells Is Mobilized By G-CSF Alone Compared to the Addition of Plerixafor: Autologous Blood Stem Cell Graft Composition Collected after Various Mobilization Methods
BIOL BLOOD MARROW TR. 2016; 22(3):S137-S137.-BMT Tandem Meetings; FEB 18-22, 2016; Honolulu, HI.
Doi: 10.1016/j.bbmt.2015.11.473
[Poster]
Web of Science
FullText
FullText_MUG
** Worel, N; Lehner, E; Rabitsch, W; Mitterbauer, M; Bauer, W; Schulenburg, A; Hopfinger, G; Just, U; Stary, G; Kalhs, P; Greinix, H
Extracorporeal photopheresis in patients with steroid-refractory acute graft-versus-host disease: does the number of UVA-treated leukocytes impact response to therapy?
BONE MARROW TRANSPL. 2016; 51: S375-S376.-42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation; APR 03-06, 2016; Valencia, SPAIN.
[Poster]
Web of Science
** Balavarca, Y; Pearce, K; Norden, J; Collin, M; Jackson, G; Holler, E; Dressel, R; Kolb, HJ; Greinix, H; Socie, G; Toubert, A; Rocha, V; Gluckman, E; Hromadnikova, I; Sedlacek, P; Wolff, D; Holtick, U; Dickinson, A; Bickeböller, H
Predicting survival using clinical risk scores and non-HLA immunogenetics.
Bone Marrow Transplant. 2015; 50(11):1445-1452
Doi: 10.1038/bmt.2015.173
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brüggen, MC; Petzelbauer, P; Greinix, H; Contassot, E; Jankovic, D; French, L; Socié, G; Rabitsch, W; Kuzmina, Z; Kalhs, P; Knobler, R; Stingl, G; Stary, G
Epidermal elafin expression is an indicator of poor prognosis in cutaneous graft-versus-host disease.
J Invest Dermatol. 2015; 135(4):999-1006
Doi: 10.1038/jid.2014.489
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Frey Tirri, B; Häusermann, P; Bertz, H; Greinix, H; Lawitschka, A; Schwarze, CP; Wolff, D; Halter, JP; Dörfler, D; Moffat, R
Clinical guidelines for gynecologic care after hematopoietic SCT. Report from the international consensus project on clinical practice in chronic GVHD.
Bone Marrow Transplant. 2015; 50(1):3-9
Doi: 10.1038/bmt.2014.242
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gratwohl, A; Pasquini, MC; Aljurf, M; Atsuta, Y; Baldomero, H; Foeken, L; Gratwohl, M; Bouzas, LF; Confer, D; Frauendorfer, K; Gluckman, E; Greinix, H; Horowitz, M; Iida, M; Lipton, J; Madrigal, A; Mohty, M; Noel, L; Novitzky, N; Nunez, J; Oudshoorn, M; Passweg, J; van Rood, J; Szer, J; Blume, K; Appelbaum, FR; Kodera, Y; Niederwieser, D; Worldwide Network for Blood and Marrow Transplantation (WBMT)
One million haemopoietic stem-cell transplants: a retrospective observational study.
Lancet Haematol. 2015; 2(3):e91-100
Doi: 10.1016/S2352-3026(15)00028-9
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Kuzmina, Z; Weigl, R; Körmoczi, U; Rottal, A; Wolff, D; Kralj, M; Kalhs, P; Mitterbauer, M; Rabitsch, W; Edinger, M; Holler, E; Pickl, WF
CD19+CD21low B cells and CD4+CD45RA+CD31+ T cells correlate with first diagnosis of chronic graft-versus-host disease.
Biol Blood Marrow Transplant. 2015; 21(2):250-258
Doi: 10.1016/j.bbmt.2014.11.010
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Harrison, N; Mitterbauer, M; Tobudic, S; Kalhs, P; Rabitsch, W; Greinix, H; Burgmann, H; Willinger, B; Presterl, E; Forstner, C
Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort study.
BMC Infect Dis. 2015; 15(7):584-584
Doi: 10.1186/s12879-015-1329-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hillen, U; Häusermann, P; Massi, D; Janin, A; Wolff, D; Lawitschka, A; Greinix, H; Meyer, R; Ziemer, M
Consensus on performing skin biopsies, laboratory workup, evaluation of tissue samples and reporting of the results in patients with suspected cutaneous graft-versus-host disease.
J Eur Acad Dermatol Venereol. 2015; 29(5):948-954
Doi: 10.1111/jdv.12737
Web of Science
PubMed
FullText
FullText_MUG
** Iacobelli, S; de Wreede, LC; Schönland, S; Björkstrand, B; Hegenbart, U; Gruber, A; Greinix, H; Volin, L; Narni, F; Carella, AM; Beksac, M; Bosi, A; Milone, G; Corradini, P; Friberg, K; van Biezen, A; Goldschmidt, H; de Witte, T; Morris, C; Niederwieser, D; Garderet, L; Kröger, N; Gahrton, G; EBMT CMWP, Plasma Cell Disorders Subcommittee
Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial.
Bone Marrow Transplant. 2015; 50(4):505-510
Doi: 10.1038/bmt.2014.310
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jagasia, MH; Greinix, HT; Arora, M; Williams, KM; Wolff, D; Cowen, EW; Palmer, J; Weisdorf, D; Treister, NS; Cheng, GS; Kerr, H; Stratton, P; Duarte, RF; McDonald, GB; Inamoto, Y; Vigorito, A; Arai, S; Datiles, MB; Jacobsohn, D; Heller, T; Kitko, CL; Mitchell, SA; Martin, PJ; Shulman, H; Wu, RS; Cutler, CS; Vogelsang, GB; Lee, SJ; Pavletic, SZ; Flowers, ME
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.
Biol Blood Marrow Transplant. 2015; 21(3):389-401
Doi: 10.1016/j.bbmt.2014.12.001
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lamm, W; Wohlfarth, P; Bojic, M; Schörgenhofer, C; Drach, J; Gisslinger, H; Worel, N; Schiefer, A; Schulenburg, A; Agis, H; Kalhs, P; Greinix, HT; Schellongowski, P; Rabitsch, W
Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience.
Oncology. 2015; 89(4): 196-204.
Doi: 10.1159/000437055
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Buser, A; Greinix, HT; Hägglund, H; Navarro, W; Pulsipher, MA; Nicoloso de Faveri, G; Bengtsson, M; Billen, A; Espino, G; Fechter, M; Giudice, V; Hölig, K; Kanamori, H; Kodera, Y; Leitner, G; Netelenbos, T; Niederwieser, D; van Walraven, SM; Rocha, V; Torosian, T; Vergueiro, C; Weisdorf, D; Yabe, H; Halter, JP
Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.
Biol Blood Marrow Transplant. 2015; 21(12):2052-2060
Doi: 10.1016/j.bbmt.2015.08.009
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hilgendorf, I; Greinix, H; Halter, JP; Lawitschka, A; Bertz, H; Wolff, D
Long-term follow-up after allogeneic stem cell transplantation.
Dtsch Arztebl Int. 2015; 112(4): 51-58.
Doi: 10.3238/arztebl.2015.0051
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Inamoto, Y; Shah, NN; Savani, BN; Shaw, BE; Abraham, AA; Ahmed, IA; Akpek, G; Atsuta, Y; Baker, KS; Basak, GW; Bitan, M; DeFilipp, Z; Gregory, TK; Greinix, HT; Hamadani, M; Hamilton, BK; Hayashi, RJ; Jacobsohn, DA; Kamble, RT; Kasow, KA; Khera, N; Lazarus, HM; Malone, AK; Lupo-Stanghellini, MT; Margossian, SP; Muffly, LS; Norkin, M; Ramanathan, M; Salooja, N; Schoemans, H; Wingard, JR; Wirk, B; Wood, WA; Yong, A; Duncan, CN; Flowers, ME; Majhail, NS
Secondary solid cancer screening following hematopoietic cell transplantation.
Bone Marrow Transplant. 2015; 50(8):1013-1023
Doi: 10.1038/bmt.2015.63
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Aberer, F; Mader, JK; Kremser, S; Zinke-Cerwenka, W; Greinix, H; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Wölfler, A; Sourij, H
Glykämie nach allogener Stammzelltransplantation bei Patienten mit akuter myeloischer Leukämie (AML) ist ein unabhängiger Prädiktor für das Überleben.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S135.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Poster]
Web of Science
** Aberer, F; Stauber, MN; Mader, JK; Greinix, H; Oulhaj, A; Wölfler, A; Sourij, H
Assoziation zwischen Hyperglykämie und ungünstigem Outcome bei Patienten mit akuter oder chronischer Graft-versus-Host Erkrankung (GvHD) nach allogener Stammzelltransplantation.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S156-S157.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Bainschab, A; Quehenberger, F; Greinix, HT; Krause, R; Wolfler, A; Sill, H; Zebisch, A
Efficacy of antibiotic prophylaxis in AML patients treated with low-intensity therapeutic regimens
ONCOL RES TREAT. 2015; 38: 73-74.
[Poster]
Web of Science
** Balsiger, C; Mumm, F; Holler, E; Herzberg, PY; Hilgendorf, I; Hemmati, P; von Harsdorf, S; Greinix, H; Mitchell, SA; Wolff, D; Heussner, P
Correlation between somatic comorbidities and anxiety and depression in patients after allogeneic hematopoietic stem cell transplantation
ONCOL RES TREAT. 2015; 38: 148-148.
[Oral Communication]
Web of Science
** Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B
Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
CL LYMPH MYELOM LEUK. 2015; 15: S183-S183.
[Oral Communication]
Web of Science
** Deutsch, AJA; Rinner, B; Wenzl, K; Troppan, K; Pursche, B; Greinix, HT; Beham-Schmid, C; Neumeister, P
NR4A3 Possesses Tumor Suppressive Properties like NR4A1 By Regulating Pro-Apoptotic Genes in Aggressive Lymphomas and Serves As a Potential Drug Target for Lymphoma Therapy
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Duarte, RF; Boumendil, A; Onida, F; Finel, H; Gabriel, IH; Arcese, W; Browne, P; Beelen, DW; Kobbe, G; Veelken, JH; Arranz, R; Greinix, HT; Lenhoff, S; Poire, X; Ribera, J; Thompson, J; Zuckerman, T; Mufti, GJ; Cortelezzi, A; Olavarria, E; Sureda, A; Dreger, P
Allogeneic Hematopoietic Cell Transplantation (HCT) for Advanced Mycosis Fungoides and Sezary Syndrome (MF/SS): Impact of Increasing the Use of Unrelated Donors (UD) - the EBMT Lymphoma Working Party Experience
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Oral Communication]
Web of Science
** Greinix, HT
Acute and chronic GVHD: State of the art therapy
ONCOL RES TREAT. 2015; 38: 114-114.
[Keynote lecture]
Web of Science
** Helene, S; Goris, K; Van Durm, R; Van Hoof, J; Greinix, HT; Wolff, D; Pavletic, SZ; Lee, SJ; Maertens, J; De Geest, S; Dobbels, F; Duarte, RF
Development and Preliminary Usability and Accuracy Testing of the EBMT Gvhd App to Support Graft Versus Host Disease Diagnosis and Scoring According to NIH Criteria, By the EBMT Complications and Quality of Life Working Party
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Kralj, M; Kuzmina, Z; Weigl, R; Rottal, A; Kormoczi, U; Pick, W; Greinix, H
CD19+CD21low B-cells as biomarker for the prediction and monitoring of response to immunosuppressive therapy for chronic graft-versus-host disease
ONCOL RES TREAT. 2015; 38: 127-127.
[Poster]
Web of Science
** Stauber, M; Aberer, F; Zebisch, A; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A
Steroid-induced hyperglycemia adversely impacts outcome in graft-versus-host disease
ONCOL RES TREAT. 2015; 38: 129-129.
[Poster]
Web of Science
** Troppan, K; Wenzl, K; Neumeister, P; Beham-Schmid, C; Przekopowitz, M; Greinix, HT; Schaider, H; Deutsch, AJA
The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome
BLOOD. 2015; 126(23):-55th Annual Meeting and Exposition of the American-Society-of-Hematology; DEC 07-10, 2013; New Orleans, LA.
[Poster]
Web of Science
** Wenzl, K; Troppan, K; Pursche, B; Bischof, M; Beham-Schmid, C; Greinix, HT; Neumeister, P; Deutsch, AJA
Loss of NR4A1 Accelerates the Development of Aggressive Lymphomas in Myc Induced Cancerogenesis
BLOOD. 2015; 126(23):-57th Annual Meeting of the American-Society-of-Hematology; DEC 05-08, 2015; Orlando, FL.
[Poster]
Web of Science
** Boehm, A; Sperr, WR; Kalhs, P; Greinix, H; Valent, P; Worel, N; Kainz, A; Mitterbauer, M; Bojic, M; Rabitsch, W
Long-term follow-up after allogeneic stem cell transplantation in patients with myelodysplastic syndromes or secondary acute myeloid leukemia: a single center experience.
Wien Klin Wochenschr. 2014; 126(1-2): 23-29.
Doi: 10.1007/s00508-013-0449-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brüggen, MC; Klein, I; Greinix, H; Bauer, W; Kuzmina, Z; Rabitsch, W; Kalhs, P; Petzelbauer, P; Knobler, R; Stingl, G; Stary, G
Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease.
Blood. 2014; 123(2): 290-299.
Doi: 10.1182/blood-2013-07-514372
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Das-Gupta, E; Greinix, H; Jacobs, R; Zhou, L; Savani, BN; Engelhardt, BG; Kassim, A; Worel, N; Knobler, R; Russell, N; Jagasia, M
Extracorporeal photopheresis as second-line treatment for acute graft-versus-host disease: impact on six-month freedom from treatment failure.
Haematologica. 2014; 99(11):1746-1752
Doi: 10.3324/haematol.2014.108217
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Duarte, RF; Greinix, H; Rabin, B; Mitchell, SA; Basak, G; Wolff, D; Madrigal, JA; Pavletic, SZ; Lee, SJ
Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.
Bone Marrow Transplant. 2014; 49(1): 49-54.
Doi: 10.1038/bmt.2013.129
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Knobler, R; Berlin, G; Calzavara-Pinton, P; Greinix, H; Jaksch, P; Laroche, L; Ludvigsson, J; Quaglino, P; Reinisch, W; Scarisbrick, J; Schwarz, T; Wolf, P; Arenberger, P; Assaf, C; Bagot, M; Barr, M; Bohbot, A; Bruckner-Tuderman, L; Dreno, B; Enk, A; French, L; Gniadecki, R; Gollnick, H; Hertl, M; Jantschitsch, C; Jung, A; Just, U; Klemke, CD; Lippert, U; Luger, T; Papadavid, E; Pehamberger, H; Ranki, A; Stadler, R; Sterry, W; Wolf, IH; Worm, M; Zic, J; Zouboulis, CC; Hillen, U
Guidelines on the use of extracorporeal photopheresis.
J Eur Acad Dermatol Venereol. 2014; 28 Suppl 1:1-37
Doi: 10.1111/jdv.12311
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lawitschka, A; Güclü, ED; Varni, JW; Putz, M; Wolff, D; Pavletic, S; Greinix, H; Peters, C; Felder-Puig, R
Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study.
Bone Marrow Transplant. 2014; 49(8):1093-1097
Doi: 10.1038/bmt.2014.96
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Böhm, A; Bojic, M; Schellongowski, P; Wöhrer, S; Sliwa, T; Keil, F; Worel, N; Greinix, H; Hauswirth, A; Kalhs, P; Jaeger, U; Valent, P; Sperr, WR
Clofarabine/cyclophosphamide for debulking before stem cell transplantation.
Eur J Clin Invest. 2014; 44(8):775-783
Doi: 10.1111/eci.12294
Web of Science
PubMed
FullText
FullText_MUG
** Ruutu, T; Gratwohl, A; de Witte, T; Afanasyev, B; Apperley, J; Bacigalupo, A; Dazzi, F; Dreger, P; Duarte, R; Finke, J; Garderet, L; Greinix, H; Holler, E; Kröger, N; Lawitschka, A; Mohty, M; Nagler, A; Passweg, J; Ringdén, O; Socié, G; Sierra, J; Sureda, A; Wiktor-Jedrzejczak, W; Madrigal, A; Niederwieser, D
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice.
Bone Marrow Transplant. 2014; 49(2): 168-173.
Doi: 10.1038/bmt.2013.107
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stift, J; Baba, HA; Huber, E; Federmann, B; Fischer, HP; Schmitt-Graeff, A; Baurmann, H; Bethge, W; Schirmacher, P; Wrba, F; Greinix, H; Fend, F; Schwerdtfeger, R; Shulman, HM; Wolff, D; Longerich, T; Liver Pathology Group of the German-Austrian-Swiss Working Group on GvHD
Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.
Virchows Arch. 2014; 464(2): 175-190.
Doi: 10.1007/s00428-013-1528-8
Web of Science
PubMed
FullText
FullText_MUG
** Weissinger, EM; Metzger, J; Dobbelstein, C; Wolff, D; Schleuning, M; Kuzmina, Z; Greinix, H; Dickinson, AM; Mullen, W; Kreipe, H; Hamwi, I; Morgan, M; Krons, A; Tchebotarenko, I; Ihlenburg-Schwarz, D; Dammann, E; Collin, M; Ehrlich, S; Diedrich, H; Stadler, M; Eder, M; Holler, E; Mischak, H; Krauter, J; Ganser, A
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation.
Leukemia. 2014; 28(4): 842-852.
Doi: 10.1038/leu.2013.210
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ziemer, M; Haeusermann, P; Janin, A; Massi, D; Ziepert, M; Wolff, D; Greinix, H; Hillen, U
Histopathological diagnosis of graft-versus-host disease of the skin: an interobserver comparison.
J Eur Acad Dermatol Venereol. 2014; 28(7):915-924
Doi: 10.1111/jdv.12215
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Worel, N; Just, U; Knobler, R
Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
Transfus Apher Sci. 2014; 50(3):349-357
Doi: 10.1016/j.transci.2014.04.005
Web of Science
PubMed
FullText
FullText_MUG
** Pearce, KF; Hildebrandt, M; Greinix, H; Scheding, S; Koehl, U; Worel, N; Apperley, J; Edinger, M; Hauser, A; Mischak-Weissinger, E; Dickinson, AM; Lowdell, MW
Regulation of advanced therapy medicinal products in Europe and the role of academia.
Cytotherapy. 2014; 16(3): 289-297.
Doi: 10.1016/j.jcyt.2013.08.003
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B
Allogeneic Stem Cell Transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
ONCOL RES TREAT. 2014; 37: 134-134.
[Poster]
Web of Science
** Gahrton, G; Iacobelli, S; Björkstrand, B; Hegenbart, U; Gruber, A; Greinix, H; Volin, L; Narni, F; Carella, AM; Beksac, M; Bosi, A; Milone, G; Corradini, P; Schönland, S; Friberg, K; van Biezen, A; Goldschmidt, H; de Witte, T; Morris, C; Niederwieser, D; Garderet, L; Kröger, N; EBMT Chronic Malignancies Working Party Plasma Cell Disorders Subcommittee
Autologous/reduced-intensity allogeneic stem cell transplantation vs autologous transplantation in multiple myeloma: long-term results of the EBMT-NMAM2000 study.
Blood. 2013; 121(25): 5055-5063.
Doi: 10.1182/blood-2012-11-469452
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Halter, JP; van Walraven, SM; Worel, N; Bengtsson, M; Hägglund, H; Nicoloso de Faveri, G; Shaw, BE; Schmidt, AH; Fechter, M; Madrigal, A; Szer, J; Aljurf, MD; Weisdorf, D; Horowitz, MM; Greinix, H; Niederwieser, D; Gratwohl, A; Kodera, Y; Confer, D
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).
Bone Marrow Transplant. 2013; 48(2):220-225
Doi: 10.1038/bmt.2012.119
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Herzberg, PY; Lee, SJ; Heussner, P; Mumm, FH; Hilgendorf, I; von Harsdorf, S; Hemmati, P; Rieger, K; Greinix, HT; Freund, M; Holler, E; Wolff, D
Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
Bone Marrow Transplant. 2013; 48(1):129-134
Doi: 10.1038/bmt.2012.83
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Jagasia, M; Greinix, H; Robin, M; Das-Gupta, E; Jacobs, R; Savani, BN; Engelhardt, BG; Kassim, A; Worel, N; Knobler, R; Russell, N; Socie, G
Extracorporeal photopheresis versus anticytokine therapy as a second-line treatment for steroid-refractory acute GVHD: a multicenter comparative analysis.
Biol Blood Marrow Transplant. 2013; 19(7): 1129-1133.
Doi: 10.1016/j.bbmt.2013.04.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kuzmina, Z; Krenn, K; Petkov, V; Körmöczi, U; Weigl, R; Rottal, A; Kalhs, P; Mitterbauer, M; Ponhold, L; Dekan, G; Greinix, HT; Pickl, WF
CD19(+)CD21(low) B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome.
Blood. 2013; 121(10): 1886-1895.
Doi: 10.1182/blood-2012-06-435008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pfeiffer, T; Schleuning, M; Mayer, J; Haude, KH; Tischer, J; Buchholz, S; Bunjes, D; Bug, G; Holler, E; Meyer, RG; Greinix, H; Scheid, C; Christopeit, M; Schnittger, S; Braess, J; Schlimok, G; Spiekermann, K; Ganser, A; Kolb, HJ; Schmid, C
Influence of molecular subgroups on outcome of acute myeloid leukemia with normal karyotype in 141 patients undergoing salvage allogeneic stem cell transplantation in primary induction failure or beyond first relapse.
Haematologica. 2013; 98(4):518-525
Doi: 10.3324/haematol.2012.070235
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vogl, UM; Nagayama, K; Bojic, M; Hoda, MA; Klepetko, W; Jaksch, P; Dekan, S; Siersch, V; Mitterbauer, M; Schellongowski, P; Greinix, HT; Petkov, V; Schulenburg, A; Kalhs, P; Rabitsch, W
Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience.
Transplantation. 2013; 95(4): 623-628.
Doi: 10.1097/TP.0b013e318277e29e
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Ayuk, F; Elmaagacli, A; Bertz, H; Lawitschka, A; Schleuning, M; Meyer, RG; Gerbitz, A; Hilgendorf, I; Hildebrandt, GC; Edinger, M; Klein, S; Halter, J; Mousset, S; Holler, E; Greinix, HT
Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.
Biol Blood Marrow Transplant. 2013; 19(5): 767-776.
Doi: 10.1016/j.bbmt.2013.01.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B;
Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S393-S393. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013)
[Poster]
Web of Science
** Dietrich-Ntoukas, T; Cursiefen, C; Westekemper, H; Eberwein, P; Reinhard, T; Bertz, H; Nepp, J; Lawitschka, A; Heiligenhaus, A; Seitz, B; Messmer, EM; Meyer-ter-Vehn, T; Basara, N; Greinix, H; Datiles, MB; Lee, SJ; Pavletic, SZ; Wolff, D
Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD.
Cornea. 2012; 31(3): 299-310.
Doi: 10.1097/ICO.0b013e318226bf97
Web of Science
PubMed
FullText
FullText_MUG
** Dreger, P; Döhner, H; McClanahan, F; Busch, R; Ritgen, M; Greinix, H; Fink, AM; Knauf, W; Stadler, M; Pfreundschuh, M; Dührsen, U; Brittinger, G; Hensel, M; Schetelig, J; Winkler, D; Bühler, A; Kneba, M; Schmitz, N; Hallek, M; Stilgenbauer, S; German CLL Study Group
Early autologous stem cell transplantation for chronic lymphocytic leukemia: long-term follow-up of the German CLL Study Group CLL3 trial.
Blood. 2012; 119(21):4851-4859
Doi: 10.1182/blood-2011-09-378505
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Tanew, A
UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
Curr Probl Dermatol. 2012; 43(9):116-131
Doi: 10.1159/000335404
PubMed
FullText
FullText_MUG
** Just, U; Dimou, E; Knobler, R; Klosner, G; Ivancic-Brandenberger, E; Greinix, H; Becherer, A; Trautinger, F
Leucocyte scintigraphy with 111In-oxine for assessment of cell trafficking after extracorporeal photopheresis.
Exp Dermatol. 2012; 21(6):443-447
Doi: 10.1111/j.1600-0625.2012.01491.x
Web of Science
PubMed
FullText
FullText_MUG
** Kuzmina, Z; Eder, S; Böhm, A; Pernicka, E; Vormittag, L; Kalhs, P; Petkov, V; Stary, G; Nepp, J; Knobler, R; Just, U; Krenn, K; Worel, N; Greinix, HT
Significantly worse survival of patients with NIH-defined chronic graft-versus-host disease and thrombocytopenia or progressive onset type: results of a prospective study.
Leukemia. 2012; 26(4):746-756
Doi: 10.1038/leu.2011.257
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Nagler, A; Labopin, M; Shimoni, A; Niederwieser, D; Mufti, GJ; Zander, AR; Arnold, R; Greinix, H; Cornelissen, JJ; Jackson, GH; Craddock, C; Bunjes, DW; Ganser, A; Russell, NH; Kyrcz-Krzemien, S; Rocha, V; Mohty, M
Mobilized peripheral blood stem cells compared with bone marrow as the stem cell source for unrelated donor allogeneic transplantation with reduced-intensity conditioning in patients with acute myeloid leukemia in complete remission: an analysis from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant. 2012; 18(9):1422-1429
Doi: 10.1016/j.bbmt.2012.02.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ringdén, O; Labopin, M; Beelen, DW; Volin, L; Ehninger, G; Finke, J; Greinix, HT; Kyrcz-Krzemien, S; Bunjes, D; Brinch, L; Niederwieser, D; Arnold, R; Mohty, M; Rocha, V; Acute Leukaemia Working Party of European Group for Blood and Marrow Transplantation (EBMT)
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients.
J Intern Med. 2012; 272(5):472-483
Doi: 10.1111/j.1365-2796.2012.02547.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rosenmayr, A; Pointner-Prager, M; Mitterschiffthaler, A; Bozic, L; Pelzmann, B; Tüchler, H; Fae, I; Fischer, GF; Greinix, HT; Peters, Ch; Kalhs, P; Krieger, O; Linkesch, W; Nachbaur, D; Urban, Ch; Posch, U; Lanzer, G; Gabriel, Ch; Schennach, H; Mayr, WR
What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country.
Bone Marrow Transplant. 2012; 47(2):172-180
Doi: 10.1038/bmt.2011.67
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Böhm, A; Rabitsch, W; Leitner, G; Mitterbauer, M; Kalhs, P; Mayr, WR; Schwartz, D; Greinix, HT
Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioning.
Transfusion. 2012; 52(6):1348-1353
Doi: 10.1111/j.1537-2995.2011.03457.x
Web of Science
PubMed
FullText
FullText_MUG
** Björkstrand, B; Iacobelli, S; Hegenbart, U; Gruber, A; Greinix, H; Volin, L; Narni, F; Musto, P; Beksac, M; Bosi, A; Milone, G; Corradini, P; Goldschmidt, H; de Witte, T; Morris, C; Niederwieser, D; Gahrton, G
Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.
J Clin Oncol. 2011; 29(22):3016-3022
Doi: 10.1200/JCO.2010.32.7312
Web of Science
PubMed
FullText
FullText_MUG
** Boehm, A; Walcherberger, B; Sperr, WR; Wöhrer, S; Dieckmann, K; Rosenmayr, A; Pernicka, E; Fischer, G; Worel, N; Mitterbauer, G; Schwarzinger, I; Mitterbauer, M; Haas, OA; Lechner, K; Hinterberger, W; Valent, P; Greinix, HT; Rabitsch, W; Kalhs, P
Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
Biol Blood Marrow Transplant. 2011; 17(1): 133-140.
Doi: 10.1016/j.bbmt.2010.06.019
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Craddock, C; Labopin, M; Pillai, S; Finke, J; Bunjes, D; Greinix, H; Ehninger, G; Steckel, NK; Zander, AR; Schwerdtfeger, R; Buchholz, S; Kolb, HJ; Volin, L; Fauser, A; Polge, E; Schmid, C; Mohty, M; Rocha, V
Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia.
Leukemia. 2011; 25(5): 808-813.
Doi: 10.1038/leu.2011.13
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Loddenkemper, C; Pavletic, SZ; Holler, E; Socié, G; Lawitschka, A; Halter, J; Wolff, D
Diagnosis and staging of chronic graft-versus-host disease in the clinical practice.
Biol Blood Marrow Transplant. 2011; 17(2): 167-175.
Doi: 10.1016/j.bbmt.2010.07.017
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; van Besien, K; Elmaagacli, AH; Hillen, U; Grigg, A; Knobler, R; Parenti, D; Reddy, V; Theunissen, K; Michallet, M; Flowers, ME; UVADEX Chronic GVHD Study Group
Progressive improvement in cutaneous and extracutaneous chronic graft-versus-host disease after a 24-week course of extracorporeal photopheresis--results of a crossover randomized study.
Biol Blood Marrow Transplant. 2011; 17(12): 1775-1782.
Doi: 10.1016/j.bbmt.2011.05.004
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hilgendorf, I; Freund, M; Jilg, W; Einsele, H; Gea-Banacloche, J; Greinix, H; Halter, J; Lawitschka, A; Wolff, D; Meisel, R
Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.
Vaccine. 2011; 29(16): 2825-2833.
Doi: 10.1016/j.vaccine.2011.02.018
PubMed
FullText
FullText_MUG
** King, RJ; Confer, DL; Greinix, HT; Halter, J; Horowitz, M; Schmidt, AH; Costeas, P; Shaw, B; Egeland, T; Ethics and Clinical Working Groups of World Marrow Donor Association
Unrelated hematopoietic stem cell donors as research subjects.
Bone Marrow Transplant. 2011; 46(1): 10-13.
Doi: 10.1038/bmt.2010.37
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kuzmina, Z; Greinix, HT; Weigl, R; Körmöczi, U; Rottal, A; Frantal, S; Eder, S; Pickl, WF
Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia.
Blood. 2011; 117(7): 2265-2274.
Doi: 10.1182/blood-2010-07-295766
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Meier, JK; Wolff, D; Pavletic, S; Greinix, H; Gosau, M; Bertz, H; Lee, SJ; Lawitschka, A; Elad, S; International Consensus Conference on Clinical Practice in cGVHD
Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD.
Clin Oral Investig. 2011; 15(2): 127-139.
Doi: 10.1007/s00784-010-0450-6
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Bertz, H; Greinix, H; Lawitschka, A; Halter, J; Holler, E
The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.
Dtsch Arztebl Int. 2011; 108(43):732-740
Doi: 10.3238/arztebl.2011.0732
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Schleuning, M; von Harsdorf, S; Bacher, U; Gerbitz, A; Stadler, M; Ayuk, F; Kiani, A; Schwerdtfeger, R; Vogelsang, GB; Kobbe, G; Gramatzki, M; Lawitschka, A; Mohty, M; Pavletic, SZ; Greinix, H; Holler, E
Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant. 2011; 17(1): 1-17.
Doi: 10.1016/j.bbmt.2010.05.011
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Rosskopf, K; Neumeister, P; Kasparu, H; Nachbaur, D; Russ, G; Namberger, K; Witt, V; Schloegl, E; Zojer, N; Linkesch, W; Kalhs, P; Greinix, HT
Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion. 2011; 51(5):968-975
Doi: 10.1111/j.1537-2995.2010.02896.x
Web of Science
PubMed
FullText
FullText_MUG
** Aoki, M; Marin-Esteban, V; Weigl, R; Charron, D; Greinix, H; Moins-Teisserenc, H; Mooney, N
Decreased pro-inflammatory cytokines and increased CCR7 expression on T-lymphocyte subsets are predictive of response to extracorporeal photopheresis in patients with GvHD.
Br J Haematol. 2011; 154(3): 409-413.
Doi: 10.1111/j.1365-2141.2010.08515.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hautmann, AH; Elad, S; Lawitschka, A; Greinix, H; Bertz, H; Halter, J; Faraci, M; Hofbauer, LC; Lee, S; Wolff, D; Holler, E
Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Transpl Int. 2011; 24(9):867-879
Doi: 10.1111/j.1432-2277.2011.01264.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hildebrandt, GC; Fazekas, T; Lawitschka, A; Bertz, H; Greinix, H; Halter, J; Pavletic, SZ; Holler, E; Wolff, D
Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.
Bone Marrow Transplant. 2011; 46(10): 1283-1295.
Doi: 10.1038/bmt.2011.35
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Herzberg, PY; Heussner, P; Mumm, FH; Horak, M; Hilgendorf, I; von Harsdorf, S; Hemmati, P; Rieger, K; Greinix, H; Freund, M; Lee, SJ; Holler, E; Wolff, D
Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
Biol Blood Marrow Transplant. 2010; 16(12): 1707-1717.
Doi: 10.1016/j.bbmt.2010.05.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kyriakou, C; Canals, C; Cornelissen, JJ; Socié, G; Willemze, R; Ifrah, N; Greinix, HT; Blaise, D; Deconinck, E; Ferrant, A; Schattenberg, A; Harousseau, JL; Sureda, A; Schmitz, N
Allogeneic stem-cell transplantation in patients with Waldenström macroglobulinemia: report from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
J Clin Oncol. 2010; 28(33): 4926-4934.
Doi: 10.1200/JCO.2009.27.3607
Web of Science
PubMed
FullText
FullText_MUG
** Shaw, BE; Ball, L; Beksac, M; Bengtsson, M; Confer, D; Diler, S; Fechter, M; Greinix, H; Koh, M; Lee, S; Nicoloso-De-Faveri, G; Philippe, J; Pollichieni, S; Pulsipher, M; Schmidt, A; Yang, E; van Walraven, AM; Clinical Working Group; Ethics Working Group of the WMDA
Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.
Bone Marrow Transplant. 2010; 45(5): 832-838.
Doi: 10.1038/bmt.2010.2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Wolff, D; Gerbitz, A; Ayuk, F; Kiani, A; Hildebrandt, GC; Vogelsang, GB; Elad, S; Lawitschka, A; Socie, G; Pavletic, SZ; Holler, E; Greinix, H
Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.
Biol Blood Marrow Transplant. 2010; 16(12): 1611-1628.
Doi: 10.1016/j.bbmt.2010.06.015
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Stary, G; Geusau, A; Greinix, H; Vormittag, L; Stingl, G; Rabitsch, W
Epstein-Barr virus-associated oral papulosis in graft-versus-host disease.
Acta Derm Venereol. 2010; 90(5): 542-543.
Doi: 10.2340/00015555-0903
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Grauer, O; Wolff, D; Bertz, H; Greinix, H; Kühl, JS; Lawitschka, A; Lee, SJ; Pavletic, SZ; Holler, E; Kleiter, I
Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Brain. 2010; 133(10): 2852-2865.
Doi: 10.1093/brain/awq245
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Krieger, O; Machhemdl-Spandl, S; Hauser, H; Binder, M; Greinix, H; Eder, S; Kahls, P; Rabitsch, W; Nachbaur, D; Ludwig, H; Linkesch, W; Jaeger, G; Sill, H; Lindner, B
Stem cell transplantation for MDS patients 1987-2008: data from the Austrian transplant registry (ASCTR)
BONE MARROW TRANSPLANT. 2010; 45: S180-S181. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
** Worel, N; Rosskopf, K; Agis, H; Nachbaur, D; Kasparu, H; Russ, G; Keil, F; Linkesch, W; Greinix, H
PLERIXAFOR PLUS G-CSF CAN SUCCESSFULLY MOBILIZE CD34+CELLS FROM PATIENTS WHO HAVE PREVIOUSLY FAILED CHEMOTHERAPY AND/OR CYTOKINE MOBILIZATION: THE COMPASSIONATE USE EXPERIENCE IN AUSTRIA
VOX SANG. 2010; 99: 9-10.
[Poster]
Web of Science
** Worel, N; Rosskopf, K; Nachbaur, D; Kasparu, H; Russ, G; Namberger, K; Leitner, G; Kalhs, P; Schogl, E; Witt, V; Greinix, H; Keil, F; Linkesch, W
Plerixafor plus G-CSF can successfully mobilize CD34+cells from patients who have previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in Austria
BONE MARROW TRANSPLANT. 2010; 45: S318-S318. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA.
[Poster]
Web of Science
** Greinix, HT; Worel, N; Knobler, R
Role of extracorporeal photopheresis (ECP) in treatment of steroid-refractory acute graft-versus-host disease.
Biol Blood Marrow Transplant. 2010; 16(12): 1747-1748.
Doi: 10.1016/j.bbmt.2010.06.012
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Chang, YY; Greinix, HT; Dickinson, AM; Wolff, D; Jackson, GH; Andreesen, R; Holler, E; Hildebrandt, GC
G to C transition at position -173 of MIF gene of the recipient is associated with reduced relapse rates after allogeneic stem cell transplantation.
Cytokine. 2009; 48(3): 218-225.
Doi: 10.1016/j.cyto.2009.07.012
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Worel, N
New agents for mobilizing peripheral blood stem cells.
Transfus Apher Sci. 2009; 41(1): 67-71.
Doi: 10.1016/j.transci.2009.05.015
Web of Science
PubMed
FullText
FullText_MUG
** Halter, J; Kodera, Y; Ispizua, AU; Greinix, HT; Schmitz, N; Favre, G; Baldomero, H; Niederwieser, D; Apperley, JF; Gratwohl, A
Severe events in donors after allogeneic hematopoietic stem cell donation.
Haematologica. 2009; 94(1): 94-101.
Doi: 10.3324/haematol.13668
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Holler, E; Kolb, HJ; Greinix, H; Perrotin, D; Campilho, F; Aversa, F; Gil, L; Cornelissen, J; Varanese, L; Schacht, A; Friese, A; Rustige, J
Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.
Bone Marrow Transplant. 2009; 43(6): 491-497.
Doi: 10.1038/bmt.2008.337
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, GC; Baumgartner, K; Kalhs, P; Biener, D; Greinix, HT; Hoecker, P; Worel, N
Regeneration, health status and quality of life after rhG-CSF-stimulated stem cell collection in healthy donors: a cross-sectional study.
Bone Marrow Transplant. 2009; 43(5): 357-363.
Doi: 10.1038/bmt.2008.335
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ludajic, K; Balavarca, Y; Bickeböller, H; Rosenmayr, A; Fae, I; Fischer, GF; Kouba, M; Pohlreich, D; Kalhs, P; Greinix, HT
KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.
Bone Marrow Transplant. 2009; 44(2): 97-103.
Doi: 10.1038/bmt.2008.432
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ludajic, K; Balavarca, Y; Bickeböller, H; Rosenmayr, A; Fischer, GF; Faé, I; Kalhs, P; Pohlreich, D; Kouba, M; Dobrovolna, M; Greinix, HT
Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients.
Biol Blood Marrow Transplant. 2009; 15(11): 1400-1406.
Doi: 10.1016/j.bbmt.2009.07.002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Pfistershammer, K; Lawitschka, A; Klauser, C; Leitner, J; Weigl, R; Heemskerk, MH; Pickl, WF; Majdic, O; Böhmig, GA; Fischer, GF; Greinix, HT; Steinberger, P
Allogeneic disparities in immunoglobulin-like transcript 5 induce potent antibody responses in hematopoietic stem cell transplant recipients.
Blood. 2009; 114(11): 2323-2332.
Doi: 10.1182/blood-2008-10-183814
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kuzmina, Z; Greinix, HT; Knobler, R; Worel, N; Kouba, M; Weigl, R; Körmöczi, U; Rottal, A; Pohlreich, D; Zielinski, C; Pickl, WF
Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease.
Blood. 2009; 114(3): 744-746.
Doi: 10.1182/blood-2009-05-221028
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Knobler, R; Barr, ML; Couriel, DR; Ferrara, JL; French, LE; Jaksch, P; Reinisch, W; Rook, AH; Schwarz, T; Greinix, H
Extracorporeal photopheresis: past, present, and future.
J Am Acad Dermatol. 2009; 61(4): 652-665.
Doi: 10.1016/j.jaad.2009.02.039
Web of Science
PubMed
FullText
FullText_MUG
** Ludajic, K; Rosenmayr, A; Faé, I; Fischer, GF; Balavarca, Y; Bickeböller, H; Kalhs, P; Greinix, HT
Association of HLA-E polymorphism with the outcome of hematopoietic stem-cell transplantation with unrelated donors.
Transplantation. 2009; 88(10): 1227-1228.
Doi: 10.1097/TP.0b013e3181bbb8fe
Web of Science
PubMed
FullText
FullText_MUG
** Flowers, ME; Apperley, JF; van Besien, K; Elmaagacli, A; Grigg, A; Reddy, V; Bacigalupo, A; Kolb, HJ; Bouzas, L; Michallet, M; Prince, HM; Knobler, R; Parenti, D; Gallo, J; Greinix, HT
A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease.
Blood. 2008; 112(7): 2667-2674.
Doi: 10.1182/blood-2008-03-141481
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Pohlreich, D; Kouba, M; Körmöczi, U; Lohmann, I; Feldmann, K; Zielinski, C; Pickl, WF
Elevated numbers of immature/transitional CD21- B lymphocytes and deficiency of memory CD27+ B cells identify patients with active chronic graft-versus-host disease.
Biol Blood Marrow Transplant. 2008; 14(2): 208-219.
Doi: 10.1016/j.bbmt.2007.10.009
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hildebrandt, GC; Granell, M; Urbano-Ispizua, A; Wolff, D; Hertenstein, B; Greinix, HT; Brenmoehl, J; Schulz, C; Dickinson, AM; Hahn, J; Rogler, G; Andreesen, R; Holler, E
Recipient NOD2/CARD15 variants: a novel independent risk factor for the development of bronchiolitis obliterans after allogeneic stem cell transplantation.
Biol Blood Marrow Transplant. 2008; 14(1): 67-74.
Doi: 10.1016/j.bbmt.2007.09.009
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Holler, E; Rogler, G; Brenmoehl, J; Hahn, J; Greinix, H; Dickinson, AM; Socie, G; Wolff, D; Finke, J; Fischer, G; Jackson, G; Rocha, V; Hilgendorf, I; Eissner, G; Marienhagen, J; Andreesen, R
The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation.
Int J Immunogenet. 2008; 35(4-5): 381-384.
Doi: 10.1111/j.1744-313X.2008.00795.x
Web of Science
PubMed
FullText
FullText_MUG
** Kircher, B; Niederwieser, D; Gächter, A; Lindner, B; Mitterschiffthaler, A; Urban, C; Greinix, H; Peters, C; Lätzer, K; Gastl, G; Nachbaur, D
T-cell precursor frequencies and long-term outcome following unrelated hematopoietic stem cell transplantation.
Int J Lab Hematol. 2008; 30(6):499-507
Doi: 10.1111/j.1751-553X.2007.00990.x
Web of Science
PubMed
FullText
FullText_MUG
** Ludajic, K; Balavarca, Y; Bickeböller, H; Pohlreich, D; Kouba, M; Dobrovolna, M; Vrana, M; Rosenmayr, A; Fischer, GF; Fae, I; Kalhs, P; Greinix, HT
Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT.
Br J Haematol. 2008; 142(3): 436-443.
Doi: 10.1111/j.1365-2141.2008.07177.x
Web of Science
PubMed
FullText
FullText_MUG
** Sacchi, N; Costeas, P; Hartwell, L; Hurley, CK; Raffoux, C; Rosenmayr, A; Greinix, H; Quality Assurance and Clinical Working Groups of the World Marrow Donor Association
Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.
Bone Marrow Transplant. 2008; 42(1): 9-14.
Doi: 10.1038/bmt.2008.76
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Setterblad, N; Garban, F; Weigl, R; Assier, E; Drillat, P; Charron, D; Dickinson, A; Greinix, H; Mooney, N
Extracorporeal photophoresis increases sensitivity of monocytes from patients with graft-versus-host disease to HLA-DR-mediated cell death.
Transfusion. 2008; 48(1): 169-177.
Doi: 10.1111/j.1537-2995.2007.01502.x
Web of Science
PubMed
FullText
FullText_MUG
** Ruck, S; Hilgendorf, I; Müller-Hilke, B; Kiefel, V; Junghanss, C; Freund, M; Greinix, H; Wolff, D
Autoantibody-mediated agranulocytosis in association with chronic GVHD.
Bone Marrow Transplant. 2008; 42(5): 359-360.
Doi: 10.1038/bmt.2008.173
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Avivi, I; Canals, C; Niederwieser, D; Kanz, L; Finke, J; Greinix, H; Nagler, A; Vaernant, JP; Bregni, M; Haioun, C; Linkesch, W; Schwerdtfeger, R; Sureda, A
Matched unrelated donor stem cell transplantation for patients with diffuse large cell B cell lymphoma: a retrospective analysis of 118 patients registered through the European Group for Blood and Marrow Transplantation (EBMT)
BONE MARROW TRANSPLANT. 2008; 41: S43-S43.-34 th Meeting of the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY.
[Keynote lecture]
Web of Science
** Holler, E; Hahn, J; Andreesen, R; Rogler, G; Brenmoehl, J; Greinix, H; Dickinson, AM; Socie, G; Wolff, D; Finke, J
NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters.
J Clin Oncol. 2008; 26(2): 338-339.
Doi: 10.1200/JCO.2007.14.1325
Web of Science
PubMed
FullText
FullText_MUG
** Bourhis, JH; Bouko, Y; Koscielny, S; Bakkus, M; Greinix, H; Derigs, G; Salles, G; Feremans, W; Apperley, J; Samson, D; Björkstrand, B; Niederwieser, D; Gahrton, G; Pico, JL; Goldschmidt, H; European Group for Blood and Marrow Transplantation
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
Haematologica. 2007; 92(8): 1083-1090.
Doi: 10.3324/haematol.10535
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Pohlreich, D; Maalouf, J; Soukup, P; Supper, V; Kalhs, P; Knobler, RM
A single-center pilot validation study of a new chronic GVHD skin scoring system.
Biol Blood Marrow Transplant. 2007; 13(6): 715-723.
Doi: 10.1016/j.bbmt.2007.02.007
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ullmann, AJ; Lipton, JH; Vesole, DH; Chandrasekar, P; Langston, A; Tarantolo, SR; Greinix, H; Morais de Azevedo, W; Reddy, V; Boparai, N; Pedicone, L; Patino, H; Durrant, S
Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.
N Engl J Med. 2007; 356(4): 335-347.
Doi: 10.1056/NEJMoa061098
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Greinix, HT; Leitner, G; Mitterbauer, M; Rabitsch, W; Rosenmayr, A; Höcker, P; Kalhs, P
ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy.
Transfus Apher Sci. 2007; 36(3): 297-304.
Doi: 10.1016/j.transci.2007.03.004
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Greinix, HT; Supper, V; Leitner, G; Mitterbauer, M; Rabitsch, W; Fischer, G; Rosenmayr, A; Höcker, P; Kalhs, P
Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Transfusion. 2007; 47(8): 1494-1502.
Doi: 10.1111/j.1537-2995.2007.01289.x
Web of Science
PubMed
FullText
FullText_MUG
** Urban, C; Schwinger, W; Benesch, M; Sovinz, P; Henze, G; Greinix, H
Autologous cord blood transplantation in a child with acute lymphoblastic leukemia and central nervous system relapse.
Pediatrics. 2007; 119(5):1042-1043
Doi: 10.1542/peds.2007-0554
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Deininger, M; Schleuning, M; Greinix, H; Sayer, HG; Fischer, T; Martinez, J; Maziarz, R; Olavarria, E; Verdonck, L; Schaefer, K; Boqué, C; Faber, E; Nagler, A; Pogliani, E; Russell, N; Volin, L; Schanz, U; Doelken, G; Kiehl, M; Fauser, A; Druker, B; Sureda, A; Iacobelli, S; Brand, R; Krahl, R; Lange, T; Hochhaus, A; Gratwohl, A; Kolb, H; Niederwieser, D; European Blood and Marrow Transplantation Group
The effect of prior exposure to imatinib on transplant-related mortality.
Haematologica. 2006; 91(4): 452-459.
[OPEN ACCESS]
Web of Science
PubMed
** Gorin, NC; Labopin, M; Boiron, JM; Theorin, N; Littlewood, T; Slavin, S; Greinix, H; Cahn, JY; Alessandrino, EP; Rambaldi, A; Nagler, A; Polge, E; Rocha, V; Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation
Results of genoidentical hemopoietic stem cell transplantation with reduced intensity conditioning for acute myelocytic leukemia: higher doses of stem cells infused benefit patients receiving transplants in second remission or beyond--the Acute Leukemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation.
J Clin Oncol. 2006; 24(24): 3959-3966.
Doi: 10.1200/JCO.2006.05.5855
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Knobler, RM; Worel, N; Schneider, B; Schneeberger, A; Hoecker, P; Mitterbauer, M; Rabitsch, W; Schulenburg, A; Kalhs, P
The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease.
Haematologica. 2006; 91(3): 405-408.
[OPEN ACCESS]
Web of Science
PubMed
** Hegenbart, U; Niederwieser, D; Sandmaier, BM; Maris, MB; Shizuru, JA; Greinix, H; Cordonnier, C; Rio, B; Gratwohl, A; Lange, T; Al-Ali, H; Storer, B; Maloney, D; McSweeney, P; Chauncey, T; Agura, E; Bruno, B; Maziarz, RT; Petersen, F; Storb, R
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
J Clin Oncol. 2006; 24(3): 444-453.
Doi: 10.1200/JCO.2005.03.1765
Web of Science
PubMed
FullText
FullText_MUG
** Holler, E; Rogler, G; Brenmoehl, J; Hahn, J; Herfarth, H; Greinix, H; Dickinson, AM; Socié, G; Wolff, D; Fischer, G; Jackson, G; Rocha, V; Steiner, B; Eissner, G; Marienhagen, J; Schoelmerich, J; Andreesen, R
Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination.
Blood. 2006; 107(10): 4189-4193.
Doi: 10.1182/blood-2005-09-3741
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kerjaschki, D; Huttary, N; Raab, I; Regele, H; Bojarski-Nagy, K; Bartel, G; Kröber, SM; Greinix, H; Rosenmaier, A; Karlhofer, F; Wick, N; Mazal, PR
Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants.
Nat Med. 2006; 12(2): 230-234.
Doi: 10.1038/nm1340
Web of Science
PubMed
FullText
FullText_MUG
** Pavletic, SZ; Martin, P; Lee, SJ; Mitchell, S; Jacobsohn, D; Cowen, EW; Turner, ML; Akpek, G; Gilman, A; McDonald, G; Schubert, M; Berger, A; Bross, P; Chien, JW; Couriel, D; Dunn, JP; Fall-Dickson, J; Farrell, A; Flowers, ME; Greinix, H; Hirschfeld, S; Gerber, L; Kim, S; Knobler, R; Lachenbruch, PA; Miller, FW; Mittleman, B; Papadopoulos, E; Parsons, SK; Przepiorka, D; Robinson, M; Ward, M; Reeve, B; Rider, LG; Shulman, H; Schultz, KR; Weisdorf, D; Vogelsang, GB; Response Criteria Working Group
Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. Response Criteria Working Group report.
Biol Blood Marrow Transplant. 2006; 12(3): 252-266.
Doi: 10.1016/j.bbmt.2006.01.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schmid, C; Schleuning, M; Schwerdtfeger, R; Hertenstein, B; Mischak-Weissinger, E; Bunjes, D; Harsdorf, SV; Scheid, C; Holtick, U; Greinix, H; Keil, F; Schneider, B; Sandherr, M; Bug, G; Tischer, J; Ledderose, G; Hallek, M; Hiddemann, W; Kolb, HJ
Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.
Blood. 2006; 108(3): 1092-1099.
Doi: 10.1182/blood-2005-10-4165
Web of Science
PubMed
FullText
FullText_MUG
** Wang, XN; Collin, M; Sviland, L; Marshall, S; Jackson, G; Schulz, U; Holler, E; Karrer, S; Greinix, H; Elahi, F; Hromadnikova, I; Dickinson, AM
Skin explant model of human graft-versus-host disease: prediction of clinical outcome and correlation with biological risk factors.
Biol Blood Marrow Transplant. 2006; 12(2): 152-159.
Doi: 10.1016/j.bbmt.2005.09.018
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Schulenburg, A; Mitterbauer, M; Keil, F; Rabitsch, W; Kalhs, P; Gisslinger, H; Raderer, M; Geissler, K; Höcker, P; Zielinski, CC; Oberbauer, R; Greinix, HT
Autologous stem-cell transplantation in progressing amyloidosis is associated with severe transplant-related toxicity.
Wien Klin Wochenschr. 2006; 118(1-2): 49-53.
Doi: 10.1007/s00508-005-0505-x
Web of Science
PubMed
FullText
FullText_MUG
** Langner, S; Staber, PB; Zebisch, A; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Greinix, H; Kalhs, P; Rabitsch, W; Neumeister, P
Adding palifermin in allogeneic and autologous stem cell transplantation resulted in reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels.
BLOOD. 2006; 108(11): 404B-404B.
Doi: 10.1182/blood.V108.11.5251.5251
[Poster]
Web of Science
FullText
FullText_MUG
** Greinix, HT; Socié, G; Bacigalupo, A; Holler, E; Edinger, MG; Apperley, JF; Schwarz, T; Ullrich, SE; Albert, ML; Knobler, RM; Peritt, D; Ferrara, JL
Assessing the potential role of photopheresis in hematopoietic stem cell transplant.
Bone Marrow Transplant. 2006; 38(4): 265-273.
Doi: 10.1038/sj.bmt.1705440
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Faé, I; Schneider, B; Rosenmayr, A; Mitterschiffthaler, A; Pelzmann, B; Kalhs, P; Lechner, K; Mayr, WR; Fischer, GF
Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors.
Bone Marrow Transplant. 2005; 35(1): 57-62.
Doi: 10.1038/sj.bmt.1704741
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hainz, U; Obexer, P; Winkler, C; Sedlmayr, P; Takikawa, O; Greinix, H; Lawitschka, A; Pötschger, U; Fuchs, D; Ladisch, S; Heitger, A
Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.
BLOOD. 2005; 105(10): 4127-4134.
Doi: 10.1182/blood-2004-05-1726
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, GC; Stiegler, G; Kalhs, P; Greinix, HT; Rabitsch, W; Sillaber, C; Hoecker, P; Panzer, S
The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimen.
Transfusion. 2005; 45(2): 195-201.
Doi: 10.1111/j.1537-2995.2004.04115.x
Web of Science
PubMed
FullText
FullText_MUG
** Nachbaur, D; Greinix, HT; Koller, E; Krieger, O; Linkesch, W; Kasparu, H; Pober, M; Hinterberger, W; Hausmaninger, H; Heistinger, M; Ulsperger, E; Karlhuber, S; Schwinger, W; Lindner, B
Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
Ann Hematol. 2005; 84(7):462-473
Doi: 10.1007/s00277-004-1003-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rabitsch, W; Staudinger, T; Locker, GJ; Köstler, WJ; Laczika, K; Frass, M; Knoebl, P; Greinix, HT; Kalhs, P; Keil, F
Respiratory failure after stem cell transplantation: improved outcome with non-invasive ventilation.
Leuk Lymphoma. 2005; 46(8): 1151-1157.
Doi: 10.1080/10428190500097649
Web of Science
PubMed
FullText
FullText_MUG
** Schulenburg, A; Fischer, M; Kalhs, P; Mitterbauer, M; Rabitsch, W; Greinix, HT; Leitner, G
Immune recovery after conventional and non-myeloablative allogeneic stem cell transplantation.
Leuk Lymphoma. 2005; 46(12): 1755-1760.
Doi: 10.1080/10428190500264496
Web of Science
PubMed
FullText
FullText_MUG
** Jayne, D; Passweg, J; Marmont, A; Farge, D; Zhao, X; Arnold, R; Hiepe, F; Lisukov, I; Musso, M; Ou-Yang, J; Marsh, J; Wulffraat, N; Besalduch, J; Bingham, SJ; Emery, P; Brune, M; Fassas, A; Faulkner, L; Ferster, A; Fiehn, C; Fouillard, L; Geromin, A; Greinix, H; Rabusin, M; Saccardi, R; Schneider, P; Zintl, F; Gratwohl, A; Tyndall, A; European Group for Blood and Marrow Transplantation; European League Against Rheumatism Registry
Autologous stem cell transplantation for systemic lupus erythematosus.
Lupus. 2004; 13(3): 168-176.
Doi: 10.1191/0961203304lu525oa
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, M; Mitterbauer-Hohendanner, G; Sperr, WR; Kalhs, P; Greinix, HT; Fonatsch, C; Haas, OA; Jäger, U; Mannhalter, C; Lechner, K
Molecular disease eradication is a prerequisite for long-term remission in patients with t(8;21) positive acute myeloid leukemia: a single center study.
Leuk Lymphoma. 2004; 45(5): 971-977.
Doi: 10.1080/10428190310001638913
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Prinz, E; Ackermann, J; Wöhrer, S; Kaufmann, H; Seidl, S; Keil, F; Kalhs, P; Greinix, H; Gisslinger, H; Leitner, G; Drach, J
Long-term follow up of patients with multiple myeloma after high-dose chemotherapy and allogeneic stem cell transplantation.
Eur J Haematol. 2004; 72(1): 26-31.
Doi: 10.1046/j.0902-4441.2004.00178.x
Web of Science
PubMed
FullText
FullText_MUG
** Schmidt, HH; Strehl, S; Thaler, D; Strunk, D; Sill, H; Linkesch, W; Jäger, U; Sperr, W; Greinix, HT; König, M; Emberger, W; Haas, OA
RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Leukemia. 2004; 18(6):1115-1121
Doi: 10.1038/sj.leu.2403353
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulenburg, A; Turetschek, K; Wrba, F; Vogelsang, H; Greinix, HT; Keil, F; Mitterbauer, M; Kalhs, P
Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation.
Ann Hematol. 2004; 83(2): 101-106.
Doi: 10.1007/s00277-003-0756-4
Web of Science
PubMed
FullText
FullText_MUG
** Simonitsch-Klupp, I; Hauser, I; Ott, G; Drach, J; Ackermann, J; Kaufmann, J; Weltermann, A; Greinix, HT; Skrabs, C; Dittrich, C; Lutz, D; Pötter, R; Mannhalter, C; Lechner, K; Chott, A; Jaeger, U
Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome.
Leukemia. 2004; 18(1): 146-155.
Doi: 10.1038/sj.leu.2403206
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Weltermann, A; Fonatsch, C; Haas, OA; Greinix, HT; Kahls, P; Mitterbauer, G; Jäger, U; Kainz, B; Geissler, K; Valent, P; Sperr, WR; Knöbl, P; Schwarzinger, I; Gleiss, A; Lechner, K
Impact of cytogenetics on the prognosis of adults with de novo AML in first relapse.
Leukemia. 2004; 18(2): 293-302.
Doi: 10.1038/sj.leu.2403243
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Ludwig, H; Zojer, N; Linkesch, W; Kahls, P; Krieger, O; Greinix, HT; Hinterberger, W; Pittermann, E; Bauernhofer, T; Gastl, G
Results of autologous transplantation for multiple myeloma (MM) in Austria. An analysis based on data from the Austrian Stem Cell Transplantation (ASCT) Registry
J CLIN ONCOL 2004 22: 596S-596S.
Web of Science
** Kaufmann, H; Ackermann, J; Greinix, H; Nösslinger, T; Gisslinger, H; Keck, A; Ludwig, H; Worel, N; Kalhs, P; Zielinski, C; Drach, J
Beneficial effect of high-dose chemotherapy in multiple myeloma patients with unfavorable prognostic features.
Ann Oncol. 2003; 14(11):1667-1672
Doi: 10.1093/annonc/mdg454
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Keil, F; Prinz, E; Moser, K; Mannhalter, C; Kalhs, P; Worel, N; Rabitsch, W; Schulenburg, A; Mitterbauer, M; Greinix, H
Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-free survival.
Transplantation. 2003; 76(1):230-236
Doi: 10.1097/01.TP.0000071862.42835.76
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, GC; Tanzmann, A; Stiegler, G; Kalhs, P; Greinix, HT; Hoecker, P; Panzer, S
Influence of human platelet antigen match on the success of stem cell transplantation after myeloablative conditioning.
Bone Marrow Transplant. 2003; 32(8):821-824
Doi: 10.1038/sj.bmt.1704222
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Peniket, AJ; Ruiz de Elvira, MC; Taghipour, G; Cordonnier, C; Gluckman, E; de Witte, T; Santini, G; Blaise, D; Greinix, H; Ferrant, A; Cornelissen, J; Schmitz, N; Goldstone, AH; European Bone Marrow Transplantation (EBMT) Lymphoma Registry
An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Bone Marrow Transplant. 2003; 31(8):667-678
Doi: 10.1038/sj.bmt.1703891
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Prinz, E; Keil, F; Kalhs, P; Mitterbauer, M; Rabitsch, W; Rosenmayr, A; Moser, K; Schulenburg, A; Lechner, K; Greinix, HT
Successful immunotherapy in early relapse of acute myeloid leukemia after nonmyeloablative allogeneic stem cell transplantation.
Ann Hematol. 2003; 82(5):295-298
Doi: 10.1007/s00277-003-0621-5
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Knöbl, P; Prinz, E; Keil, F; Greinix, H; Kalhs, P; Worel, N; Jansen, M; Hörl, WH; Derfler, K
Prolonged red cell aplasia after major ABO-incompatible allogeneic hematopoietic stem cell transplantation: removal of persisting isohemagglutinins with Ig-Therasorb immunoadsorption.
Bone Marrow Transplant. 2003; 32(10):1015-1019
Doi: 10.1038/sj.bmt.1704264
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Vinatzer, U; Mannhalter, C; Mitterbauer, M; Gruener, H; Greinix, H; Schmidt, HH; Fonatsch, C; Wieser, R
Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia.
Genes Chromosomes Cancer. 2003; 36(1):80-89
Doi: 10.1002/gcc.10144
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Kalhs, P; Keil, F; Prinz, E; Moser, K; Schulenburg, A; Mitterbauer, M; Mannhalter, C; Mayr, WR; Schwarzinger, I; Höcker, P; Lechner, K; Greinix, HT
ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation.
Transfusion. 2003; 43(8):1153-1161
Doi: 10.1046/j.1537-2995.2003.00465.x
Web of Science
PubMed
FullText
FullText_MUG
** Fazeny-Dörner, B; Wenzel, C; Berzlanovich, A; Sunder-Plassmann, G; Greinix, H; Marosi, C; Muhm, M
Central venous catheter pinch-off and fracture: recognition, prevention and management.
Bone Marrow Transplant. 2003; 31(10):927-930
Doi: 10.1038/sj.bmt.1704022
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Knöbl, P; Greinix, H; Prinz, E; Kalhs, P; Hörl, WH; Derfler, K
Removal of persisting isohaemagglutinins with Ig-Therasorb immunoadsorption after major ABO-incompatible non-myeloablative allogeneic haematopoietic stem cell transplantation.
Nephrol Dial Transplant. 2003; 18(11):2405-2408
Doi: 10.1093/ndt/gfg364
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Filipits, M; Pohl, G; Stranzl, T; Kaufmann, H; Ackermann, J; Gisslinger, H; Greinix, H; Chott, A; Drach, J
Low p27Kip1 expression is an independent adverse prognostic factor in patients with multiple myeloma.
Clin Cancer Res. 2003; 9(2):820-826
Web of Science
PubMed
** Becherer, A; Mitterbauer, M; Jaeger, U; Kalhs, P; Greinix, HT; Karanikas, G; Pötzi, C; Raderer, M; Dudczak, R; Kletter, K
Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.
Leukemia. 2002; 16(2):260-267
Doi: 10.1038/sj.leu.2402342
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brunner, M; Greinix, HT; Redlich, K; Knöbl, P; Smolen, J; Leitner, G; Derfler, K; Graninger, W; Kalhs, P; Machold, K
Autologous blood stem cell transplantation in refractory systemic lupus erythematosus with severe pulmonary impairment: a case report.
Arthritis Rheum. 2002; 46(6):1580-1584
Doi: 10.1002/art.10282
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Greinix, HT
DLI or second transplant.
Ann Hematol. 2002; 81 Suppl 2(5):S34-S35
Web of Science
PubMed
** Greinix, HT; Nachbaur, D; Krieger, O; Eibl, M; Knöbl, P; Kalhs, P; Lutz, D; Linkesch, W; Niederwieser, D; Hinterberger, W; Lechner, K; Rosenmayr, A; Gritsch, B
Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Br J Haematol. 2002; 117(4):914-923
Doi: 10.1046/j.1365-2141.2002.03532.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Keil, F; Elahi, F; Greinix, HT; Fritsch, G; Louda, N; Petzer, AL; Prinz, E; Wagner, T; Kalhs, P; Lechner, K; Geissler, K
Ex vivo expansion of long-term culture initiating marrow cells by IL-10, SCF, and IL-3.
Transfusion. 2002; 42(5):581-587
Doi: 10.1046/j.1537-2995.2002.00102.x
Web of Science
PubMed
FullText
FullText_MUG
** Kokalj, A; Greinix, HT; Ciovica, M; Kittler, H; Kalhs, P; Knobler, RM; Volc-Platzer, B
Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host disease.
Clin Immunol. 2002; 104(3):248-255
Doi: 10.1006/clim.2001.5240
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, M; Kalhs, P; Keil, F; Prinz, E; Moser, K; Mannhalter, C; Mitterbauer, G; Brugger, S; Gisslinger, H; Lechner, K; Greinix, HT
Continuous complete clinical and molecular remission in two patients with refractory lymphoid malignancies after autografting followed by allogeneic stem cell transplantation with reduced intensity conditioning.
Br J Haematol. 2002; 118(1):132-135
Doi: 10.1046/j.1365-2141.2002.03562.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Brugger, SA; Trubel, W; Keil, F; Greinix, HT; Kalhs, P
Streptococcus pneumoniae mycotic aortic aneurysm after allogeneic bone marrow transplantation.
Transplantation. 2002; 74(7):1048-1050
Doi: 10.1097/01.TP.0000026308.30476.C0
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Biener, D; Kalhs, P; Mitterbauer, M; Keil, F; Schulenburg, A; Höcker, P; Dieckmann, K; Fischer, G; Rosenmayr, A; Linkesch, W; Hinterberger, W; Lechner, K; Greinix, HT
Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
Bone Marrow Transplant. 2002; 30(9):619-626
Doi: 10.1038/sj.bmt.1703677
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Worel, N; Greinix, HT; Keil, F; Mitterbauer, M; Lechner, K; Fischer, G; Mayr, W; Höcker, P; Kalhs, P
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Transfusion. 2002; 42(10):1293-1301
Doi: 10.1046/j.1537-2995.2002.00209.x
Web of Science
PubMed
FullText
FullText_MUG
** Dettke, M; Greinix, HT; Kalhs, P; Kührer, I; Worel, N; Höcker, P
Kinetics of PBPC mobilization by cyclophosphamide, as compared with that by epirubicin/paclitaxel followed by G-CSF support: implications for optimal timing of PBPC harvest.
Transfusion. 2001; 41(5):681-686
Doi: 10.1046/j.1537-2995.2001.41050681.x
Web of Science
PubMed
FullText
FullText_MUG
** Dettke, M; Jurko, S; Rüger, BM; Leitner, G; Greinix, HT; Kalhs, P; Fischer, MB; Höcker, P
Increased serum flt3-ligand in healthy donors undergoing granulocyte colony-stimulating factor-induced peripheral stem cell mobilization.
J Hematother Stem Cell Res. 2001; 10(2):317-320
Doi: 10.1089/15258160151135105
Web of Science
PubMed
FullText
FullText_MUG
** Gaiger, A; Carter, L; Greinix, H; Carter, D; McNeill, PD; Houghton, RL; Cornellison, CD; Vedvick, TS; Skeiky, YA; Cheever, MA
WT1-specific serum antibodies in patients with leukemia.
Clin Cancer Res. 2001; 7(3 Suppl):761s-7765
Web of Science
PubMed
** Keil, F; Mitterbauer, G; Chen, X; Haas, OA; Kalhs, P; Lechner, K; Mannhalter, C; Moser, K; Worel, N; Pirc-Danoewinata, H; Louda, N; Loidolt, H; Rabitsch, W; Greinix, HT
PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR.
Transfusion. 2001; 41(1):111-116
Doi: 10.1046/j.1537-2995.2001.41010111.x
Web of Science
PubMed
FullText
FullText_MUG
** Keil, F; Prinz, E; Kalhs, P; Lechner, K; Moser, K; Schwarzinger, I; Jäger, U; Fonatsch, C; Worel, N; Mannhalter, C; Rabitsch, W; Loidolt, H; Schulenburg, A; Mitterbauer, M; Höcker, P; Greinix, HT
Treatment of leukemic relapse after allogeneic stem cell transplantation with cytotoreductive chemotherapy and/or immunotherapy or second transplants.
Leukemia. 2001; 15(3):355-361
Doi: 10.1038/sj.leu.2402048
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kurz, M; Knöbl, P; Kalhs, P; Greinix, HT; Höcker, P; Panzer, S
Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments:a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test.
Transfusion. 2001; 41(6):771-774
Doi: 10.1046/j.1537-2995.2001.41060771.x
Web of Science
PubMed
FullText
FullText_MUG
** Laczika, K; Mitterbauer, G; Mitterbauer, M; Knöbl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Leuk Lymphoma. 2001; 42(5):923-931
Doi: 10.3109/10428190109097711
Web of Science
PubMed
FullText
FullText_MUG
** Leitner, G; Loidolt, H; Greinix, HT; Höcker, P; Dettke, M
Granulocyte colony-stimulating factor-induced allogeneic peripheral stem cell donation during early pregnancy.
Br J Haematol. 2001; 115(1):233-234
Doi: 10.1046/j.1365-2141.2001.115_1cr-5.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, M; Neumeister, P; Kalhs, P; Brugger, S; Fischer, G; Dieckmann, K; Hoecker, P; Hinterberger, W; Linkesch, W; Simonitsch, I; Jaeger, U; Lechner, K; Mannhalter, C; Mitterbauer, G; Greinix, HT
Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma.
Leukemia. 2001; 15(4):635-641
Doi: 10.1038/sj.leu.2402053
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rabitsch, W; Deviatko, E; Keil, F; Herold, C; Dekan, G; Greinix, HT; Lechner, K; Klepetko, W; Kalhs, P
Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation.
Transplantation. 2001; 71(9):1341-1343
Doi: 10.1097/00007890-200105150-00028
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Schulenburg, A; Watkins-Riedel, T; Greinix, HT; Rabitsch, W; Loidolt, H; Keil, F; Mitterbauer, M; Kalhs, P
CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR.
Bone Marrow Transplant. 2001; 28(8):765-768
Doi: 10.1038/sj.bmt.1703227
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Greinix, H; Ackermann, J; Kaufmann, H; Urbauer, E; Höcker, P; Gisslinger, H; Lechner, K; Kalhs, P; Drach, J
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma.
Ann Hematol. 2001; 80(6):345-348
Doi: 10.1007/s002770100296
Web of Science
PubMed
FullText
FullText_MUG
** Zauner, C; Rabitsch, W; Schneeweiss, B; Schiefermeier, M; Greinix, HT; Keil, F; Ratheiser, K; Kalhs, P
Energy and substrate metabolism in patients with chronic extensive graft-versus-host disease.
Transplantation. 2001; 71(4):524-528
Doi: 10.1097/00007890-200102270-00007
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Nachbaur, D; Krieger, O; Eibl, M; Kalhs, P; Lutz, D; Linkesch, W; Niederwieser, D; Rosenmayr, A; Gritsch, B
Factors impacting leukemia-free and overall survival of patients with acute myelogenous leukemia after allogeneic stem cell transplantation: report of the Austrian stem cell transplantation registry
BONE MARROW TRANSPLANT. 2001; 27: S81-S81.
Web of Science
** Greinix, HT; Linkesch, W; Seifert, M; Kubista, E; Czerwenka, K; Elahi, F; Zielinski, C; Hoecker, P; Steger, G; Schulenburg, A; Neumeister, G; Rabitsch, W; Jakesz, R; Kalhs, P
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients.
Acta Oncol. 2000; 39(1):47-52
Doi: 10.1080/028418600430969
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jäger, U; Rosenmayr, A; Knöbl, P; Schwarzinger, I; Höcker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P
Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia.
Ann Hematol. 2000; 79(4):206-213
Doi: 10.1007/s002770050580
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Volc-Platzer, B; Kalhs, P; Fischer, G; Rosenmayr, A; Keil, F; Hönigsmann, H; Knobler, RM
Extracorporeal photochemotherapy in the treatment of severe steroid-refractory acute graft-versus-host disease: a pilot study.
Blood. 2000; 96(7):2426-2431
Doi: 10.1182/blood.V96.7.2426
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitger, A; Greinix, H; Mannhalter, C; Mayerl, D; Kern, H; Eder, J; Fink, FM; Niederwieser, D; Panzer-Grümayer, ER
Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation.
Transplantation. 2000; 69(11):2366-2373
Doi: 10.1097/00007890-200006150-00026
Web of Science
PubMed
FullText
FullText_MUG
** Keil, F; Chen, X; Louda, N; Zsuh, H; Schneider, B; Lechner, K; Kalhs, P; Greinix, HT
Effect of interleukin-3, stem cell factor and granulocyte-macrophage colony-stimulating factor on committed stem cells, long-term culture initiating cells and bone marrow stroma in a one-step long-term bone marrow culture.
Ann Hematol. 2000; 79(5):243-248
Doi: 10.1007/s002770050587
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, G; Zimmer, C; Pirc-Danoewinata, H; Haas, OA; Hojas, S; Schwarzinger, I; Greinix, H; Jäger, U; Lechner, K; Mannhalter, C
Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction.
Br J Haematol. 2000; 109(3):622-628
Doi: 10.1046/j.1365-2141.2000.02076.x
Web of Science
PubMed
FullText
FullText_MUG
** Reiter, E; Greinix, H; Rabitsch, W; Keil, F; Schwarzinger, I; Jaeger, U; Lechner, K; Worel, N; Streubel, B; Fonatsch, C; Mitterbauer, G; Kalhs, P
Low curative potential of bone marrow transplantation for highly aggressive acute myelogenous leukemia with inversioin inv (3)(q21q26) or homologous translocation t(3;3) (q21;q26).
Ann Hematol. 2000; 79(7):374-377
Doi: 10.1007/s002770000158
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Reiter, E; Rabitsch, W; Greinix, HT; Keil, F; Mitterbauer, G; Hinterberger, W; Haas, OA; Lechner, K; Kalhs, P
Relapse of chronic myelogenous leukemia 12 years after allogeneic marrow transplantation: successful second transplantation with allogeneic peripheral blood progenitor cells.
Leuk Lymphoma. 2000; 40(1-2):215-218
Doi: 10.3109/10428190009054900
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Worel, N; Greinix, HT; Schneider, B; Kurz, M; Rabitsch, W; Knöbl, P; Reiter, E; Derfler, K; Fischer, G; Hinterberger, W; Höcker, P; Kalhs, P
Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems.
Transfusion. 2000; 40(5):543-550
Doi: 10.1046/j.1537-2995.2000.40050543.x
Web of Science
PubMed
FullText
FullText_MUG
** Schulenburg, A; Kalhs, P; Worel, N; Höcker, P; Knöbl, P; Greinix, HT
Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases.
Bone Marrow Transplant. 2000; 25(2):223-224
Doi: 10.1038/sj.bmt.1702124
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, H
Place of high-dose therapy in breast cancer. Austrotransplant consensus conference 1999].
Wien Klin Wochenschr. 2000; 112(13):601-603
Web of Science
PubMed
** Greinix, HT
Autologous stem cell transplantation in lymphomas and Hodgkin's disease].
Acta Med Austriaca Suppl. 2000; 52(3 Suppl):25-29
PubMed
** Greinix, HT; Volc-Platzer, B; Knobler, RM
Extracorporeal photochemotherapy in the treatment of severe graft-versus-host disease.
Leuk Lymphoma. 2000; 36(5-6):425-434
Doi: 10.3109/10428190009148389
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Volc-Platzer, B; Knobler, R
Criteria for assessing chronic GVHD.
Bone Marrow Transplant. 2000; 25(5):575-575
Doi: 10.1038/sj.bmt.1702183
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Endler, G; Greinix, H; Winkler, K; Mitterbauer, G; Mannhalter, C
Genetic fingerprinting in mouthwashes of patients after allogeneic bone marrow transplantation.
Bone Marrow Transplant. 1999; 24(1):95-98
Doi: 10.1038/sj.bmt.1701815
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gmeinhart, B; Hinterberger, W; Greinix, HT; Rabitsch, W; Kirnbauer, R; Reiter, E; Volc-Platzer, B
Anaplastic squamous cell carcinoma (SCC) in a patient with chronic cutaneous graft-versus-host disease (GVHD).
Bone Marrow Transplant. 1999; 23(11):1197-1199
Doi: 10.1038/sj.bmt.1701772
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Kalhs, P; Brugger, S; Reiter, E; Keil, F; Fischer, G; Schulenburg, A; Rabitsch, W; Rosenmayr, A; Dieckmann, K; Kurz, M; Schwarzinger, I; Volc-Platzer, B; Mannhalter, C; Lechner, K; Greinix, HT
Low transplant-related mortality in patients receiving unrelated donor marrow grafts for leukemia.
Bone Marrow Transplant. 1999; 23(8):753-758
Doi: 10.1038/sj.bmt.1701666
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Keil, F; Kalhs, P; Chen, X; Haas, OA; Fritsch, G; Chott, A; Lechner, K; Moser, K; Ackermann, J; Rabitsch, W; Worel, N; Mannhalter, C; Greinix, HT
Hematopoietic donor chimerism and graft-versus-myeloma effect in relapse of multiple myeloma after allogeneic bone marrow transplantation.
Ann Hematol. 1999; 78(8):376-379
Doi: 10.1007/s002770050532
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, G; Nemeth, P; Wacha, S; Cross, NC; Schwarzinger, I; Jaeger, U; Geissler, K; Greinix, HT; Kalhs, P; Lechner, K; Mannhalter, C
Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction.
Br J Haematol. 1999; 106(3):634-643
Doi: 10.1046/j.1365-2141.1999.01605.x
Web of Science
PubMed
FullText
FullText_MUG
** Reiter, E; Greinix, HT; Keil, F; Brugger, S; Rabitsch, W; Schulenburg, A; Mannhalter, C; Schwarzinger, I; Worel, N; Volc-Platzer, B; Fischer, G; Dieckmann, K; Hinterberger, W; Schneider, B; Haas, OA; Geissler, K; Kalhs, P
Long-term follow-up of patients after related- and unrelated-donor bone marrow transplantation for chronic myelogenous leukemia.
Ann Hematol. 1999; 78(11):507-513
Doi: 10.1007/s002770050547
Web of Science
PubMed
FullText
FullText_MUG
** Schulenburg, A; Herold, C; Eisenhuber, E; Oberhuber, G; Volc-Platzer, B; Greinix, HT; Reiter, E; Keil, F; Kalhs, P
Pneumatosis [correction of Pneumocystis] cystoides intestinalis with pneumoperitoneum and pneumoretroperitoneum in a patient with extensive chronic graft-versus-host disease.
Bone Marrow Transplant. 1999; 24(3):331-333
Doi: 10.1038/sj.bmt.1701897
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Kalhs, P; Herold, C; Jaeger, U; Greinix, HT
Central venous catheters inserted percutaneously via the femoral vein can be used long-term in recipients of allogeneic peripheral blood stem cell transplants.
Bone Marrow Transplant. 1999; 24(1):115-116
Doi: 10.1038/sj.bmt.1701833
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Lechner, K; Geissler, K; Jäger, U; Greinix, H; Kalhs, P
Treatment of acute leukemia.
Ann Oncol. 1999; 10 Suppl 6(5):45-51
Doi: 10.1023/A:1008380202046
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reiter, E; Kalhs, P; Keil, F; Rabitsch, W; Gisslinger, H; Mayer, G; Worel, N; Lechner, K; Greinix, HT
Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature.
Ann Hematol. 1999; 78(4):189-191
Doi: 10.1007/s002770050499
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, M; Brugger, S; Neumeister, P; Kalhs, P; Rabitsch, W; Loidolt, H; Keil, F; Hinterberger, W; Linkesch, W; Mannhalter, C; Mitterbauer, G; Greinix, H
Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
BLOOD 1999 94: 4949-4949.
Web of Science
** Becherer, A; Schulenburg, A; Bankl, HC; Schöfl, R; Keil, F; Reiter, E; Greinix, HT; Pikula, B; Kalhs, P
Bile duct adenocarcinoma mimicking veno-occlusive disease after autologous bone marrow transplantation for acute leukaemia.
Bone Marrow Transplant. 1998; 21(12):1275-1277
Doi: 10.1038/sj.bmt.1701253
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gaiger, A; Schmid, D; Heinze, G; Linnerth, B; Greinix, H; Kalhs, P; Tisljar, K; Priglinger, S; Laczika, K; Mitterbauer, M; Novak, M; Mitterbauer, G; Mannhalter, C; Haas, OA; Lechner, K; Jäger, U
Detection of the WT1 transcript by RT-PCR in complete remission has no prognostic relevance in de novo acute myeloid leukemia.
Leukemia. 1998; 12(12):1886-1894
Doi: 10.1038/sj.leu.2401213
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Reiter, E; Keil, F; Fischer, G; Lechner, K; Dieckmann, K; Leitner, G; Schulenburg, A; Hoecker, P; Haas, OA; Knoebl, P; Mannhalter, C; Fonatsch, C; Hinterberger, W; Kalhs, P
Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors.
Bone Marrow Transplant. 1998; 21(7):673-678
Doi: 10.1038/sj.bmt.1701152
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Reiter, E; Schulenburg, A; Keil, F; Lechner, K; Fischer, G; Rosenmayr, A; Leitner, G; Kalhs, P
Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
Bone Marrow Transplant. 1998; 22 Suppl 4(8):S53-S56
Web of Science
PubMed
** Greinix, HT; Volc-Platzer, B; Rabitsch, W; Gmeinhart, B; Guevara-Pineda, C; Kalhs, P; Krutmann, J; Hönigsmann, H; Ciovica, M; Knobler, RM
Successful use of extracorporeal photochemotherapy in the treatment of severe acute and chronic graft-versus-host disease.
Blood. 1998; 92(9):3098-3104
Doi: 10.1182/blood.V92.9.3098.421k32_3098_3104
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Brugger, SA; Pirker, W; Baumgartner, C; Reiter, E; Keil, F; Prayer, D; Hoecker, P; Lechner, K; Kalhs, P; Greinix, HT
Symmetrical necrosis of globus pallidus with severe gait disturbance in a patient with myelodysplastic syndrome given allogeneic marrow transplantation.
Ann Hematol. 1998; 75(5-6):235-237
Doi: 10.1007/s002770050349
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Rabitsch, W; Reiter, E; Keil, F; Malzer, R; Leitner, G; Fischer, G; Dieckman, K; Kalhs, P; Lechner, K; Greinix, HT
Experience with allogeneic and syngeneic blood stem cell transplantation in patients with hematological malignancies.
Bone Marrow Transplant. 1998; 22 Suppl 4(8):S49-S52
Web of Science
PubMed
** Rabitsch, W; Staudinger, T; Brugger, SA; Reiter, E; Keil, F; Herold, C; Lechner, K; Greinix, HT; Kalhs, P
Successful management of adult respiratory distress syndrome (ARDS) after high-dose chemotherapy and peripheral blood progenitor cell rescue by non-invasive ventilatory support.
Bone Marrow Transplant. 1998; 21(10):1067-1069
Doi: 10.1038/sj.bmt.1701215
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reiter, E; Greinix, HT; Brugger, S; Keil, F; Rabitsch, W; Mannhalter, C; Schwarzinger, I; Höcker, P; Fischer, G; Dieckmann, K; Hinterberger, W; Linkesch, W; Schneider, B; Lechner, K; Kalhs, P
Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Bone Marrow Transplant. 1998; 22 Suppl 4(8):S86-S88
Web of Science
PubMed
Google Scholar
** Reiter, E; Greinix, HT; Mitterbauer, G; Fischer, G; Keil, F; Mannhalter, C; Rabitsch, W; Schwarzinger, I; Worel, N; Lechner, K; Kalhs, P
Graft-versus-host disease following second syngeneic stem cell transplantation for relapsed chronic myeloid leukemia.
Ann Hematol. 1998; 77(6):283-286
Doi: 10.1007/s002770050459
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Schmitz, N; Bacigalupo, A; Hasenclever, D; Nagler, A; Gluckman, E; Clark, P; Bourquelot, P; Greinix, H; Frickhofen, N; Ringdén, O; Zander, A; Apperley, JF; Gorin, C; Borkett, K; Schwab, G; Goebel, M; Russell, NH; Gratwohl, A
Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation.
Bone Marrow Transplant. 1998; 21(10):995-1003
Doi: 10.1038/sj.bmt.1701234
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Schulenburg, A; Kalhs, P; Oberhuber, G; Reiter, E; Base, W; Greinix, HT
Gastrointestinal perforation early after peripheral blood stem cell transplantation for AL amyloidosis.
Bone Marrow Transplant. 1998; 22(3):293-295
Doi: 10.1038/sj.bmt.1701330
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Staudinger, T; Heimberger, K; Rabitsch, W; Schneider, B; Greinix, HT; Nowzad, S; Brugger, S; Reiter, E; Keil, F; Lechner, K; Kalhs, P
Subdural hygromas after bone marrow transplantation: results of a prospective study.
Transplantation. 1998; 65(10):1340-1344
Doi: 10.1097/00007890-199805270-00010
Web of Science
PubMed
FullText
FullText_MUG
** Lechner, K; Jäger, U; Geissler, K; Greinix, H; Kalhs, P
Advances in the treatment of chronic lymphocytic leukemia (CLL)].
Wien Klin Wochenschr. 1998; 110(20):701-708
Web of Science
PubMed
** Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W
Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
BONE MARROW TRANSPLANT. 1998; 22: S10-S10.
Web of Science
** Greinix, HT; Linkesch, W; Reiter, E; Keil, F; Seifert, M; Czerwenka, K; Elahi, F; Schulenburg, A; Hoecker, P; Kubista, E; Kalhs, P; Vienna, AKH
A novel high-dose chemotherapy including paclitaxel with CD34-selected peripheral blood stem cell (PBSC) rescue in high-risk breast cancer patients.
BONE MARROW TRANSPLANT. 1998; 21: S61-S61.
Web of Science
** Apsner, R; Schulenburg, A; Steinhoff, N; Keil, F; Janata, K; Kalhs, P; Greinix, H
Cyclosporin A-induced ocular flutter after marrow transplantation.
Bone Marrow Transplant. 1997; 20(3):255-256
Doi: 10.1038/sj.bmt.1700809
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gerber, M; Gmeinhart, B; Volc-Platzer, B; Kalhs, P; Greinix, H; Knobler, R
Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
Bone Marrow Transplant. 1997; 19(5):517-519
Doi: 10.1038/sj.bmt.1700661
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Heitger, A; Neu, N; Kern, H; Panzer-Grümayer, ER; Greinix, H; Nachbaur, D; Niederwieser, D; Fink, FM
Essential role of the thymus to reconstitute naive (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation.
Blood. 1997; 90(2):850-857
Doi: 10.1182/blood.V90.2.850.850_850_857
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Höcker, P; Kührer, I; Worel, N; Leitner, G; Kalhs, P; Greinix, H; Gerhartl, K
Positive selection of CD34+ cells by immune affinity.
Beitr Infusionsther Transfusionsmed. 1997; 34(5):166-170
Web of Science
PubMed
** Keil, F; Haas, OA; Fritsch, G; Kalhs, P; Lechner, K; Mannhalter, C; Reiter, E; Niederwieser, D; Hoecker, P; Greinix, HT
Donor leukocyte infusion for leukemic relapse after allogeneic marrow transplantation: lack of residual donor hematopoiesis predicts aplasia.
Blood. 1997; 89(9):3113-3117
Doi: 10.1182/blood.V89.9.3113
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Keil, F; Kalhs, P; Haas, OA; Fritsch, G; Reiter, E; Mannhalter, C; Lechner, K; Leitner, G; Greinix, HT
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes.
Br J Haematol. 1997; 97(1):161-164
Doi: 10.1046/j.1365-2141.1997.262674.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Pont, J; Bokemeyer, C; Harstrick, A; Sellner, F; Greinix, H; Stoiber, F
Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: a retrospective multicenter study of the Austrian Study Group on Urologic Oncology.
Ann Oncol. 1997; 8(12):1229-1234
Doi: 10.1023/A:1008286305312
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Reiter, E; Keil, F; Brugger, S; Kalhs, P; Rabitsch, W; Hinterberger, W; Fischer, G; Rosenmayr, A; Haas, O; Volc, B; Lechner, K; Greinix, HT
Excellent long-term survival after allogeneic marrow transplantation in patients with severe aplastic anemia.
Bone Marrow Transplant. 1997; 19(12):1191-1196
Doi: 10.1038/sj.bmt.1700819
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Brugger, SA; Oesterreicher, C; Hofmann, H; Kalhs, P; Greinix, HT; Müller, C
Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor.
Lancet. 1997; 349(9057):996-997
Doi: 10.1016/S0140-6736(05)62893-0
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Scholten, C; Hilgarth, B; Hilgarth, M; Jaeger, U; Greinix, HT; Mannhalter, C
Predictive value of clone-specific CDR3 PCR in high-grade non-Hodgkin's lymphoma: long-term persistence of a clone-specific rearrangement in a patient with secondary high-grade NHL in remission after high-dose therapy.
Br J Haematol. 1997; 97(1):246-247
(- Case Report)
Web of Science
PubMed
** Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
J Clin Oncol. 1996; 14(10):2638-2645
Doi: 10.1200/JCO.1996.14.10.2638
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Greinix, HT; Keil, F; Brugger, SA; Reiter, E; Linkesch, W; Lechner, K; Schneider, B; Dieckmann, KU; Fischer, G; Schwarzinger, I; Haas, O; Hinterberger, W; Mannhalter, C; Geissler, K; Hocker, P; Jager, U; Kalhs, P
Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Ann Hematol. 1996; 72(2):53-59
Doi: 10.1007/BF00641308
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Keil, F; Kalhs, P; Haas, OA; Fritsch, G; Lechner, K; Mannhalter, C; Greinix, HT
G-CSF stimulation of donor myelopoiesis prolongs survival of relapsed BCR-ABL-positive acute lymphoblastic leukemia after allogeneic marrow transplantation.
Bone Marrow Transplant. 1996; 18(3):655-657
(- Case Report)
Web of Science
PubMed
** Keil, F; Kalhs, P; Haas, OA; Fritsch, G; Mitterbauer, G; Brugger, S; Lechner, K; Schwarzinger, I; Mannhalter, C; Linkesch, W; Kurz, M; Greinix, HT
Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion.
Br J Haematol. 1996; 94(1):120-122
Doi: 10.1046/j.1365-2141.1996.d01-1770.x
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Kurz, M; Greinix, H; Höcker, P; Kalhs, P; Knöbl, P; Mayr, WR; Pober, M; Panzer, S
Specificities of anti-platelet antibodies in multitransfused patients with haemato-oncological disorders.
Br J Haematol. 1996; 95(3):564-569
Doi: 10.1046/j.1365-2141.1996.d01-1936.x
Web of Science
PubMed
FullText
FullText_MUG
** Gaiger, A; Henn, T; Hörth, E; Geissler, K; Mitterbauer, G; Maier-Dobersberger, T; Greinix, H; Mannhalter, C; Haas, OA; Lechner, K; Lion, T
Increase of bcr-abl chimeric mRNA expression in tumor cells of patients with chronic myeloid leukemia precedes disease progression.
Blood. 1995; 86(6):2371-2378
Doi: 10.1182/blood.V86.6.2371.bloodjournal8662371
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Beham-Schmid, C; Silly, H; Hoefler, G; Kasparek, A; Seewann, HL
Heavy-chain immunoglobulin gene rearrangement and cytoplasmic immunoglobulin expression in acute monocytic leukemia following primary germ cell tumor.
Ann Hematol. 1995; 70(2):109-112
Doi: 10.1007/BF01834391
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Kalhs, P; Brugger, S; Schwarzinger, I; Greinix, HT; Keil, F; Kyrle, PA; Knöbl, P; Schneider, B; Höcker, P; Linkesch, W
Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Transplantation. 1995; 60(9):949-957
Doi: 10.1097/00007890-199511150-00012
Web of Science
PubMed
FullText
FullText_MUG
** Mitterbauer, G; Födinger, M; Scherrer, R; Knöbl, P; Jäger, U; Laczika, K; Schwarzinger, I; Gaiger, A; Geissler, K; Greinix, H
PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia.
Br J Haematol. 1995; 89(4):937-941
Doi: 10.1111/j.1365-2141.1995.tb08444.x
Web of Science
PubMed
FullText
FullText_MUG
** Kalhs, P; Brugger, S; Keil, F; Hocker, P; Hawliczek, R; Hinterberger, W; Lechner, K; Linkesch, W; Greinix, HT
Allogeneic marrow transplantation beyond the age of 40 years in patients with hematological malignancy.
BLOOD. 1995; 86(10): 3791-3791.
Web of Science
** Keil, F; Kalhs, F; Haas, O; Fritsch, G; Brugger, S; Schwarzinger, ERI; Mannhalter, C; Linkesch, W; Hocker, P; Lechner, K; Greinix, HT
Prolonged aplasia after donor leukocyte infusion in relapsed CML unresponsive to bone marrow infusion: Successful treatment with cyclophosphamide and antithymocyte globulin followed by PBSC.
BLOOD. 1995; 86(10): 3794-3794.
Web of Science
** Deeg, HJ; Beckham, C; Huss, R; Myerson, D; Greinix, H; Appelbaum, FR; Graham, T; Schuening, F; Storb, R
Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand.
Blood. 1994; 83(8):2352-2359
Doi: 10.1182/blood.V83.8.2352.bloodjournal8382352
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Linkesch, W; Keil, F; Kalhs, P; Schwarzinger, I; Schneider, B; Oesterreicher, C; Brugger, S; Kapiotis, S; Lechner, K
Early detection of hematopoietic engraftment after bone marrow and peripheral blood stem cell transplantation by highly fluorescent reticulocyte counts.
Bone Marrow Transplant. 1994; 14(2):307-313
Web of Science
PubMed
Google Scholar
** Kusec, R; Laczika, K; Knöbl, P; Friedl, J; Greinix, H; Kahls, P; Linkesch, W; Schwarzinger, I; Mitterbauer, G; Purtscher, B
AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
Leukemia. 1994; 8(5):735-739
Web of Science
PubMed
Google Scholar
** Silly, H; Schmid, C; Greinix, H; Dobnig, H; Seewann, H; Neubauer, M
Suppression of chronic lymphocytic leukaemia by megakaryocytic myelosis.
Haematologia (Budap). 1994; 26(1):11-15
(- Case Report)
Web of Science
PubMed
** GREINIX, HT; KEIL, F; KNAPP, S; BRUGGER, S; KALHS, P; LINKESCH, W; LECHNER, K; JAEGER, U
ALLOGENEIC MARROW TRANSPLANTATION FOR ADVANCED-STAGE T(14-18) NON-HODGKINS-LYMPHOMA ELIMINATES PCR DETECTABLE CELLS FROM PERIPHERAL-BLOOD AND BONE-MARROW
BLOOD. 1994; 84(10): A214-A214.
Web of Science
** KALHS, P; BRUGGER, S; SCHWARZINGER, I; GREINIX, HT; KEIL, F; KYRLE, PA; KNOBL, P; LINKESCH, W; LECHNER, K
SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
BLOOD. 1994; 84(10): A489-A489.
Web of Science
** Greinix, HT; Storb, R; Sanders, JE; Deeg, HJ; Doney, KC; Sullivan, KM; Witherspoon, RP
Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome).
Br J Haematol. 1993; 84(3):515-520
Doi: 10.1111/j.1365-2141.1993.tb03109.x
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Storb, R; Bartelmez, SH
Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules.
Blood. 1992; 80(8):1950-1956
Doi: 10.1182/blood.V80.8.1950.bloodjournal8081950
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Greinix, HT; Storb, R; Sanders, JE; Petersen, FB
Marrow transplantation for treatment of multisystem progressive Langerhans cell histiocytosis.
Bone Marrow Transplant. 1992; 10(1):39-44
(- Case Report)
Web of Science
PubMed
** Greinix, HT; Ladiges, WC; Graham, TC; Maslan, S; Raff, RF; Sandmaier, BM; Appelbaum, FR; Schuening, FG; Deeg, HJ; Storb, R
Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Blood. 1991; 78(8):2131-2138
Doi: 10.1182/blood.V78.8.2131.2131
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Petry, K; Greinix, HT; Nudelman, E; Eisen, H; Hakomori, S; Levy, HL; Reichardt, JK
Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes.
Biochem Med Metab Biol. 1991; 46(1):93-104
Doi: 10.1016/0885-4505(91)90054-O
Web of Science
PubMed
FullText
FullText_MUG
** Schwarzer, S; Eber, B; Greinix, H; Lind, P
Non-Q-wave myocardial infarction associated with bleomycin and etoposide chemotherapy.
Eur Heart J. 1991; 12(6):748-750
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
** LEHNERT, M; JUTTNER, F; PETRITSCH, PH; SEEWANN, HL; GREINIX, H
CISPLATIN BASED SEQUENTIAL CHEMOTHERAPY IN FAR ADVANCED NONSEMINOMATOUS TESTICULAR CANCER (NSTC)
BLUT. 1987; 55(4): 275-275.
Web of Science
** SEEWANN, HL; GREINIX, H; URBAN, C
TREATMENT OF APLASTIC-ANEMIA WITH CYCLOSPORINE-A
BLUT. 1987; 55(4): 305-305.
Web of Science
** Urban, C; Slace, I; Kaulfersch, W; Greinix, H; Höcker, P
Treatment of stage IV neuroblastoma with high-dose melphalan and autologous bone marrow transplantation following in vitro preliminary treatment of the bone marrow with the active cyclophosphamide derivative Asta Z-7654
Padiatr Padol. 1986; 21(3):275-282
(- Case Report)
PubMed
Google Scholar
** URBAN, C; SLAVC, I; KAULFERSCH, W; GREINIX, H; HOCKER, P
TREATMENT OF NEURO-BLASTOMA, STAGE-IV WITH HIGH-DOSE MELPHALAN (HDM) FOLLOWED BY TRANSPLANTATION OF ASTA-Z CHEMOPURIFIED AUTOLOGOUS BONE-MARROW
BLUT. 1985; 51(3): 224-224.
[Oral Communication]
Web of Science